AFLAC INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
November 2, 2022 Newswires
Share
Share
Post
Email

AFLAC INC – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)

Edgar Glimpses

FORWARD-LOOKING INFORMATION


The Private Securities Litigation Reform Act of 1995 provides a safe harbor to
encourage companies to provide prospective information, so long as those
informational statements are identified as forward-looking and are accompanied
by meaningful cautionary statements identifying important factors that could
cause actual results to differ materially from those included in the
forward-looking statements. Aflac Incorporated (the Parent Company) and its
subsidiaries (collectively with the Parent Company, the Company) desire to take
advantage of these provisions. This report contains cautionary statements
identifying important factors that could cause actual results to differ
materially from those projected herein, and in any other statements made by
Company officials in communications with the financial community and contained
in documents filed with the Securities and Exchange Commission (SEC).
Forward-looking statements are not based on historical information and relate to
future operations, strategies, financial results or other developments.
Furthermore, forward-looking information is subject to numerous assumptions,
risks and uncertainties. In particular, statements containing words such as the
ones listed below or similar words, as well as specific projections of future
results, generally qualify as forward-looking. The Company undertakes no
obligation to update such forward-looking statements.

             • expect    • anticipate   • believe     • goal      • objective
             • may       • should       • estimate    • intends   • projects
             • will      • assumes      • potential   • target    • outlook

The Company cautions readers that the following factors, in addition to other
factors mentioned from time to time, could cause actual results to differ
materially from those contemplated by the forward-looking statements:


•difficult conditions in global capital markets and the economy, including those
caused by COVID-19
•defaults and credit downgrades of investments
•global fluctuations in interest rates and exposure to significant interest rate
risk
•concentration of business in Japan
•limited availability of acceptable yen-denominated investments
•foreign currency fluctuations in the yen/dollar exchange rate
•differing judgments applied to investment valuations
•significant valuation judgments in determination of expected credit losses
recorded on the Company's investments
•decreases in the Company's financial strength or debt ratings
•decline in creditworthiness of other financial institutions
•concentration of the Company's investments in any particular single-issuer or
sector
•the effects of COVID-19 and its variants (both known and emerging), and any
resulting economic effects and government interventions, on the Company's
business and financial results
•the Company's ability to attract and retain qualified sales associates,
brokers, employees, and distribution partners
•deviations in actual experience from pricing and reserving assumptions
•ability to continue to develop and implement improvements in information
technology systems
•interruption in telecommunication, information technology and other operational
systems, or a failure to maintain the security, confidentiality or privacy of
sensitive data residing on such systems
•subsidiaries' ability to pay dividends to the Parent Company
•inherent limitations to risk management policies and procedures
•operational risks of third party vendors
•tax rates applicable to the Company may change
•failure to comply with restrictions on policyholder privacy and information
security
•extensive regulation and changes in law or regulation by governmental
authorities
•competitive environment and ability to anticipate and respond to market trends
•catastrophic events, including, but not limited to, as a result of climate
change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes,
earthquakes, tsunamis, war or other military action, terrorism or other acts of
violence, and damage incidental to such events
•ability to protect the Aflac brand and the Company's reputation
•ability to effectively manage key executive succession
•changes in accounting standards
•level and outcome of litigation
•allegations or determinations of worker misclassification in the United States
                                       74
--------------------------------------------------------------------------------

                                 MD&A OVERVIEW

MD&A is intended to inform the reader about matters affecting the financial
condition and results of operations of Aflac Incorporated and its subsidiaries
for the nine-month periods ended September 30, 2022 and 2021, respectively.
Results of operations for interim periods are not necessarily indicative of
results for the entire year. As a result, the following discussion should be
read in conjunction with the consolidated financial statements and notes that
are included in the Company's annual report on Form 10-K for the year ended
December 31, 2021 (2021 Annual Report). In this MD&A, amounts may not foot due
to rounding.

This MD&A is divided into the following sections:

                                                                Page
                   Executive Summary                            76
                   Results of Operations                        77
                   Investments                                  92
                   Hedging Activities                           96
                   Deferred Policy Acquisition Costs            99
                   Policy Liabilities                          100
                   Benefit Plans                               100
                   Policyholder Protection                     100
                   Liquidity and Capital Resources             100
                   Critical Accounting Estimates               106



                                       75
--------------------------------------------------------------------------------

                               EXECUTIVE SUMMARY

Company Overview


Aflac Incorporated (the Parent Company) and its subsidiaries (collectively, the
Company) provide financial protection to more than 50 million people worldwide.
The Company's principal business is supplemental health and life insurance
products with the goal to provide customers the best value in supplemental
insurance products in the United States (U.S.) and Japan. The Company's
insurance business consists of two reporting segments: Aflac Japan and Aflac
U.S. The Parent Company's primary insurance subsidiaries are Aflac Life
Insurance Japan Ltd. in Japan (Aflac Japan) and American Family Life Assurance
Company of Columbus (Aflac); Continental American Insurance Company (CAIC),
branded as Aflac Group Insurance (AGI); American Family Life Assurance Company
of New York (Aflac New York); Tier One Insurance Company (TOIC) and Aflac
Benefits Solutions, Inc. (ABS), formerly known as Argus Dental & Vision, Inc.,
which provides a platform for Aflac Dental and Vision in the U.S. (collectively,
Aflac U.S.).

Market Conditions

The impact of the Coronavirus Disease 2019 (COVID-19) global pandemic on the
Company continues to evolve and the continued path of the global economic
recovery remains uncertain given the potential longer term impacts of the
pandemic. For example, economic conditions have acted as headwinds to sales in
the first nine months of 2022, particularly in Japan and most notably in the
first quarter with a gradually decreasing impact in the second and third
quarters, pressuring net earned premiums. Further, in the U.S., supply
shortages, upward pressure on wages to attract employees and higher commodity
prices have all driven near-term increases in inflation. Central bank and
government efforts to control inflation, as well the impacts of the
Russia-Ukraine conflict, including volatility in energy prices and additional
disruptions in the global supply chain, have led to slower economic growth in
Japan and the U.S. Additionally, continued widening of the differential between
U.S. and Japan interest rates has contributed to a weakening of the yen, which
has the effect of suppressing the Company's current period results in relation
to the comparable prior period.

In the three-month period ended September 30, 2022, sales for Aflac Japan in yen
terms increased 10.2%, compared to the same period in 2021, reflecting the
August 2022 launch of a new cancer insurance product. In the nine-month period
ended September 30, 2022, sales for Aflac Japan in yen terms decreased 4.1%,
compared to the same period in 2021, reflecting the January 2021 launch of a new
medical insurance product and continued weakness in sales recovery, in part
constrained by pandemic conditions. In the three- and nine-month periods ended
September 30, 2022, sales for Aflac U.S. increased 11.8% and 15.2%,
respectively, compared to the same periods in 2021, reflecting continued
improvement from investment in growth initiatives as well as productivity gains.

Performance Highlights


Total revenues were $4.8 billion in the third quarter of 2022, compared with
$5.2 billion in the third quarter of 2021. Net earnings were $1.6 billion, or
$2.53 per diluted share in the third quarter of 2022, compared with $888
million, or $1.32 per diluted share, in the third quarter of 2021, reflecting an
income tax benefit of $695 million from a release of deferred taxes in the third
quarter of 2022.

Total revenues were $15.5 billion in the first nine months of 2022, compared
with $16.7 billion in the first nine months of 2021. Net earnings were $4.0
billion, or $6.25 per diluted share in the first nine months of 2022, compared
with $3.3 billion, or $4.82 per diluted share, in the first nine months of 2021,
reflecting an income tax benefit of $695 million from a release of deferred
taxes in the third quarter of 2022.

Results in the third quarter of 2022 included pretax net investment gains of
$199 million, compared with pretax net investment losses of $171 million in the
third quarter of 2021. Net investment gains in the third quarter of 2022
included an increase in credit loss allowances of $11 million; $173 million of
net gains from certain derivative and foreign currency gains or losses; $22
million of net losses on equity securities; and $59 million of net gains from
sales and redemptions.

Results in the first nine months of 2022 included pretax net investment gains of
$885 million, compared with pretax net investment gains of $224 million in the
first nine months of 2021. Net investment gains in the first nine months of 2022
included an increase in credit loss allowances of $20 million; $958 million of
net gains from certain derivative and foreign currency gains or losses; $313
million of net losses on equity securities; and $260 million of net gains from
sales and redemptions.

The average yen/dollar exchange rate(1) for the three-month period ended
September 30, 2022 was 137.08, or 19.7% weaker than the average yen/dollar
exchange rate(1) of 110.11 for the same period in 2021. The average yen/dollar

                                       76
--------------------------------------------------------------------------------

exchange rate(1) for the nine-month period ended September 30, 2022 was 126.65,
or 14.3% weaker than the average yen/dollar exchange rate(1) of 108.58 for the
same period in 2021.

Adjusted earnings(2) in the third quarter of 2022 were $725 million, or $1.15
per diluted share, compared with $1.0 billion, or $1.53 per diluted share, in
the third quarter of 2021. The weaker yen/dollar exchange rate impacted adjusted
earnings per diluted share by $.08. Adjusted earnings(2) in the first nine
months of 2022 were $2.6 billion, or $4.03 per diluted share, compared with
$3.2 billion, or $4.65 per diluted share, in the first nine months of 2021. The
weaker yen/dollar exchange rate impacted adjusted earnings per diluted share by
$.23.

Total investments and cash at September 30, 2022 were $114.5 billion, compared
with $143.0 billion at December 31, 2021. In the first nine months of 2022,
Aflac Incorporated repurchased $1.8 billion, or 30.2 million of its common
shares. At September 30, 2022, the Company had 25.6 million remaining shares
authorized for repurchase.

Shareholders' equity was $24.2 billion, or $38.71 per share, at September 30,
2022, compared with $33.3 billion, or $50.99 per share, at December 31, 2021.
Shareholders' equity at September 30, 2022 included a net unrealized gain on
investment securities and derivatives of $1.1 billion, compared with a net
unrealized gain of $9.6 billion at December 31, 2021. Shareholders' equity at
September 30, 2022 also included an unrealized foreign currency translation loss
of $4.5 billion, compared with an unrealized foreign currency translation loss
of $2.0 billion at December 31, 2021. The annualized return on average
shareholders' equity in the third quarter of 2022 was 25.3%.

Shareholders' equity excluding accumulated other comprehensive income (AOCI)(2)
(adjusted book value) was $27.7 billion, or $44.34 per share at September 30,
2022, compared with $25.9 billion, or $39.65 per share, at December 31, 2021.
The annualized adjusted return on equity (ROE) excluding foreign currency
impact(2) in the third quarter of 2022 was 11.4%.

(1) Yen/U.S. dollar exchange rates are based on the published MUFG Bank, Ltd.
telegraphic transfer middle rate (TTM).
(2) See the Results of Operations section of this MD&A for a definition of this
non-U.S. GAAP financial measure.


                             RESULTS OF OPERATIONS

The Company earns its revenues principally from insurance premiums and
investments. The Company's operating expenses primarily consist of insurance
benefits provided and reserves established for anticipated future insurance
benefits, general business expenses, commissions and other costs of selling and
servicing its products. Profitability for the Company depends principally on its
ability to price its insurance products at a level that enables the Company to
earn a margin over the costs associated with providing benefits and
administering those products. Profitability also depends on, among other items,
actuarial and policyholder behavior experience on insurance products, and the
Company's ability to attract and retain customer assets, generate and maintain
favorable investment results, effectively deploy capital and utilize tax
capacity, and manage expenses.

This document includes references to the Company's financial performance
measures which are not calculated in accordance with United States generally
accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial
measures exclude items that the Company believes may obscure the underlying
fundamentals and trends in insurance operations because they tend to be driven
by general economic conditions and events or related to infrequent activities
not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese
yen, fluctuations in the yen/dollar exchange rate can have a significant effect
on reported results. In periods when the yen weakens, translating yen into
dollars results in fewer dollars being reported. When the yen strengthens,
translating yen into dollars results in more dollars being reported.
Consequently, yen weakening has the effect of suppressing current period results
in relation to the comparable prior period, while yen strengthening has the
effect of magnifying current period results in relation to the comparable prior
period. A significant portion of the Company's business is conducted in yen and
never converted into dollars but translated into dollars for U.S. GAAP reporting
purposes, which results in foreign currency impact to earnings, cash flows and
book value on a U.S. GAAP basis. Management evaluates the Company's financial
performance both including and excluding the impact of foreign currency
translation to monitor, respectively, cumulative currency impacts and the
currency-neutral operating performance over time. The average yen/dollar
exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer
middle rate (TTM).

The Company defines the non-U.S. GAAP financial measures included in this
document as follows:

                                       77
--------------------------------------------------------------------------------

•Adjusted earnings are adjusted revenues less benefits and adjusted expenses.
Adjusted earnings per share (basic or diluted) are the adjusted earnings for the
period divided by the weighted average outstanding shares (basic or diluted) for
the period presented. The adjustments to both revenues and expenses account for
certain items that cannot be predicted or that are outside management's control.
Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment
gains and losses. Adjusted expenses are U.S. GAAP total acquisition and
operating expenses including the impact of interest cash flows from derivatives
associated with notes payable but excluding any nonrecurring or other items not
associated with the normal course of the Company's insurance operations and that
do not reflect the Company's underlying business performance. Management uses
adjusted earnings and adjusted earnings per diluted share to evaluate the
financial performance of the Company's insurance operations on a consolidated
basis and believes that a presentation of these financial measures is vitally
important to an understanding of the underlying profitability drivers and trends
of the Company's insurance business. The most comparable U.S. GAAP financial
measures for adjusted earnings and adjusted earnings per share (basic or
diluted) are net earnings and net earnings per share, respectively.

•Adjusted net investment gains and losses are net investment gains and losses
adjusted for i) amortized hedge cost/income related to foreign currency exposure
management strategies and certain derivative activity, ii) net interest cash
flows from foreign currency and interest rate derivatives associated with
certain investment strategies, which are both reclassified to net investment
income, and iii) the impact of interest cash flows from derivatives associated
with notes payable, which is reclassified to interest expense as a component of
total adjusted expenses. The Company considers adjusted net investment gains and
losses important as it represents the remainder amount that is considered
outside management's control, while excluding the components that are within
management's control and are accordingly reclassified to net investment income
and interest expense. The most comparable U.S. GAAP financial measure for
adjusted net investment gains and losses is net investment gains and losses.

•Amortized hedge costs/income represent costs/income incurred or recognized as a
result of using foreign currency derivatives to hedge certain foreign exchange
risks in the Company's Japan segment or in Corporate and other. These amortized
hedge costs/ income are estimated at the inception of the derivatives based on
the specific terms of each contract and are recognized on a straight-line basis
over the term of the hedge. The Company believes that amortized hedge
costs/income measure the periodic currency risk management costs/income related
to hedging certain foreign currency exchange risks and are an important
component of net investment income. There is no comparable U.S. GAAP financial
measure for amortized hedge costs/ income.

•Adjusted earnings excluding current period foreign currency impact are computed
using the average foreign currency exchange rate for the comparable prior-year
period, which eliminates fluctuations driven solely by foreign currency exchange
rate changes. Adjusted earnings per diluted share excluding current period
foreign currency impact is adjusted earnings excluding current period foreign
currency impact divided by the weighted average outstanding diluted shares for
the period presented. The Company considers adjusted earnings excluding current
period foreign currency impact and adjusted earnings per diluted share excluding
current period foreign currency impact important because a significant portion
of the Company's business is conducted in Japan and foreign exchange rates are
outside management's control; therefore, the Company believes it is important to
understand the impact of translating foreign currency (primarily Japanese yen)
into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted
earnings excluding current period foreign currency impact and adjusted earnings
per diluted share excluding current period foreign currency impact are net
earnings and net earnings per share, respectively.

•Adjusted book value is the U.S. GAAP book value (representing total
shareholders' equity), less AOCI as recorded on the U.S. GAAP balance sheet.
Adjusted book value per common share is adjusted book value at the period end
divided by the ending outstanding common shares for the period presented. The
Company considers adjusted book value and adjusted book value per common share
important as they exclude AOCI, which fluctuates due to market movements that
are outside management's control. The most comparable U.S. GAAP financial
measures for adjusted book value and adjusted book value per common share are
total book value and total book value per common share, respectively.

•Adjusted return on equity excluding foreign currency impact is adjusted
earnings excluding the current period foreign currency impact divided by average
shareholders' equity, excluding AOCI. The Company considers adjusted return on
equity excluding foreign currency impact important as it excludes changes in
foreign currency and components of AOCI, which fluctuate due to market movements
that are outside management's control. The most comparable U.S. GAAP financial
measure for adjusted return on equity excluding foreign currency impact is ROE
as determined using net earnings and average total shareholders' equity.

                                       78
--------------------------------------------------------------------------------

•U.S. dollar-denominated investment income excluding foreign currency impact
represents amounts excluding foreign currency impact on U.S. dollar-denominated
investment income using the average foreign currency exchange rate for the
comparable prior year period. The Company considers U.S. dollar-denominated
investment income excluding foreign currency impact important as it eliminates
the impact of foreign currency changes on the Aflac Japan segment results, which
are outside management's control. The most comparable U.S. GAAP financial
measure for U.S. dollar-denominated investment income excluding foreign currency
impact is the corresponding net investment income amount from the U.S. dollar
denominated investments translated to yen.

The following table is a reconciliation of items impacting adjusted earnings and
adjusted earnings per diluted share to the most directly comparable U.S. GAAP
financial measures of net earnings and net earnings per diluted share,
respectively.

              Reconciliation of Net Earnings to Adjusted Earnings
                                          In Millions                       Per Diluted Share                       In Millions                          Per Diluted Share
                                                   Three Months Ended September 30,                                              Nine Months Ended September 30,
                                     2022             2021                2022                2021             2022             2021                2022                2021
Net earnings                      $ 1,596          $   888          $     2.53              $ 1.32          $ 4,016          $ 3,286          $     6.25              $ 4.82
Items impacting net earnings:
Adjusted net investment (gains)
losses (1)                           (222)             172                (.35)                .26             (923)            (216)              (1.44)               (.32)
Other and non-recurring (income)
loss                                   (1)               8                 .00                 .01               (1)              67                 .00                 .10
Income tax (benefit) expense on
items excluded from adjusted
earnings (2)                         (648)             (37)              (1.03)               (.06)            (501)              32                (.78)                .05

Adjusted earnings                     725            1,031                1.15                1.53            2,591            3,169                4.03                4.65
Current period foreign currency
impact (3)                             53                 N/A              .08                    N/A           147                 N/A              .23                    N/A
Adjusted earnings excluding
current period foreign currency
impact                            $   778          $ 1,031          $     1.23              $ 1.53          $ 2,738          $ 3,169          $     4.26              $ 4.65


(1) See reconciliation of net investment (gains) losses to adjusted net
investment (gains) losses below.
(2) Primarily reflects release of $695 million in deferred taxes in the third
quarter of 2022.
(3) Prior period foreign currency impact reflected as "N/A" to isolate change
for current period only.

Reconciling Items

Net Investment Gains and Losses

Reconciliation of Net Investment (Gains) Losses to Adjusted Net Investment

                                 (Gains) Losses

                                                       Three Months Ended            Nine Months Ended September
                                                          September 30,                          30,
(In millions)                                         2022             2021             2022             2021
Net investment (gains) losses                      $   (199)         $  171          $   (885)         $ (224)
Items impacting net investment (gains) losses:
Amortized hedge costs                                   (28)            (20)              (84)            (55)
Amortized hedge income                                   19              13                44              45
Net interest cash flows from derivatives
associated
 with certain investment strategies                     (26)             (6)              (36)            (23)
Interest rate component of the change in fair
value
 of foreign currency swaps on notes payable              13              14                38              41
Adjusted net investment (gains) losses             $   (222)         $  172 

$ (923) $ (216)




The Company's investment strategy is to invest primarily in fixed maturity
securities to provide a reliable stream of investment income, which is one of
the drivers of the Company's profitability. This investment strategy
incorporates asset-liability matching (ALM) to align the expected cash flows of
the portfolio to the needs of the Company's liability structure. The Company
does not purchase securities with the intent of generating investment gains or
losses. However, investment gains and losses may be realized as a result of
changes in the financial markets and the creditworthiness of specific
                                       79
--------------------------------------------------------------------------------

issuers, tax planning strategies, and/or general portfolio management and
rebalancing. The realization of investment gains and losses is independent of
the underwriting and administration of the Company's insurance products.

Net investment gains and losses excluded from adjusted earnings include the
following:


•Securities Transactions
•Credit Losses
•Changes in the Fair Value of Equity Securities
•Certain Derivative and Foreign Currency Activities.

Securities Transactions, Credit Losses and Changes in the Fair Value of Equity
Securities


Securities transactions include gains and losses from sales and redemptions of
investments where the amount received is different from the amortized cost of
the investment. Credit losses include losses for held-to-maturity fixed maturity
securities, available-for-sale fixed maturity securities, loan receivables, loan
commitments and reinsurance recoverables. Changes in the fair value of equity
securities are the result of gains or losses driven by fluctuations in market
prices.

Certain Derivative and Foreign Currency Activities

The Company's derivative activities include:


•foreign currency forwards and options used in hedging foreign exchange risk on
U.S. dollar-denominated investments in Aflac Japan's portfolio, with options
used on a standalone basis and/or in a collar strategy;

•foreign currency forwards and options used to economically hedge certain
portions of forecasted cash flows denominated in yen and hedge the Company's
long term exposure to a weakening yen;

•cross-currency interest rate swaps, also referred to as foreign currency swaps,
associated with certain senior notes and subordinated debentures;

•foreign currency swaps that are associated with variable interest entity (VIE)
bond purchase commitments, and investments in special-purpose entities,
including VIEs where the Company is the primary beneficiary;

•interest rate swaps used to economically hedge interest rate fluctuations in
certain variable-rate investments;

•interest rate swaptions used to hedge changes in the fair value associated with
interest rate fluctuations for certain U.S. dollar-denominated
available-for-sale fixed-maturity securities; and

•bond purchase commitments at the inception of investments in consolidated VIEs.


Gains and losses are recognized as a result of valuing these derivatives, net of
the effects of hedge accounting. The Company also excludes from adjusted
earnings the accounting impacts of remeasurement associated with changes in the
foreign currency exchange rate.

For additional information regarding net investment gains and losses, including
details of reported amounts for the periods presented, see Notes 3 and 4 of the
Notes to the Consolidated Financial Statements.

Other and Non-recurring Items


The U.S. insurance industry has a policyholder protection system that provides
funds for the policyholders of insolvent insurers. The system can result in
periodic charges to the Company as a result of insolvencies/bankruptcies that
occur with other companies in the life insurance industry. Some states permit
member insurers to recover assessments paid through full or partial premium tax
offsets. These charges neither relate to the ordinary course of the Company's
business nor reflect the Company's underlying business performance, but result
from external situations not controlled by the Company. The Company excludes any
charges associated with U.S. guaranty fund assessments and the corresponding tax
benefit or expense from adjusted earnings.

In Japan, the government also requires the insurance industry to contribute to a
policyholder protection corporation that provides funds for the policyholders of
insolvent insurers; however, these costs are calculated and administered
differently than in the U.S. In Japan, these costs are not directly related to
specific insolvencies or bankruptcies, but are rather a
                                       80
--------------------------------------------------------------------------------

regular operational cost for an insurance company. Based on this structure, the
Company does not remove the Japan policyholder protection expenses from adjusted
earnings.

The Company considers the costs associated with the early redemption of its debt
to be unrelated to the underlying fundamentals and trends in its insurance
operations. Additionally, these costs are driven by changes in interest rates
subsequent to the issuance of the debt, and the Company considers these interest
rate changes to represent economic conditions not directly associated with its
insurance operations. In May 2021, the Parent Company used a portion of the net
proceeds from its April 2021 issuance of various series of senior notes to
redeem $700 million of its 3.625% senior notes due June 2023. The pretax expense
due to the early redemption of these notes was $48 million.

Other items excluded from adjusted earnings include integration costs related to
the Company's acquisition of Zurich North America's U.S. Corporate Life and
Pensions business; these costs primarily consist of expenditures for legal,
accounting, consulting, integration of systems and processes and other similar
services. These integration costs are excluded from adjusted earnings for one
year following the acquisition and amounted to $8 million and $20 million for
the three- and nine-month periods ended September 30, 2021, respectively.

Income Taxes


The Company's combined U.S. and Japanese effective income tax rate on pretax
earnings was (44.7)% for the three-month period ended September 30, 2022,
compared with 20.2% for the same period in 2021. The Company's combined U.S. and
Japanese effective income tax rate on pretax earnings was 1.6% for the
nine-month period ended September 30, 2022, compared with 19.7% for the same
period in 2021. The combined effective tax rate differs from the U.S. statutory
rate primarily due to the impact of the tax accounting method change discussed
below, as well as solar, historic and foreign tax credits. For additional
information, see the Critical Accounting Estimates - Income Taxes section of
Item 7. MD&A in the 2021 Annual Report.

Aflac Japan holds certain U.S. dollar-denominated assets in a Delaware Statutory
Trust (DST). These assets are mostly comprised of various U.S.
dollar-denominated commercial mortgage loans. The functional currency of the DST
for U.S. tax purposes was historically the Japanese yen. In the third quarter of
2022, the Company requested a change in tax accounting method through the
Internal Revenue Service's automatic consent procedures to change its functional
currency on the DST for U.S. tax purposes to the U.S. dollar (USD). Based on the
volatility of foreign exchange rates between the Japanese yen and USD, the
Company's management determined that this tax accounting method better positions
the Company for U.S. tax purposes. As a result, foreign currency translation
gains or losses on assets held in the DST will no longer be recognized for U.S.
tax purposes. The Company historically recorded a deferred tax liability for
foreign currency translation gains on the DST assets, which was released in the
third quarter of 2022 as a result of the functional currency change. The release
of the deferred tax liability resulted in the Company recognizing an income tax
benefit of $695 million ($1.10 per basic and diluted share, respectively) in the
third quarter of 2022. The Company has determined that the change in tax
accounting method will impact its combined effective tax rate in future periods
as a function of changes in the foreign exchange rate between the Japanese yen
and USD.

In August 2022, the Inflation Reduction Act of 2022 (IRA) was signed into U.S.
law. Effective January 1, 2023, the law will impose a 15% alternative minimum
corporate tax rate and imposes a 1% excise tax on the Company's repurchases of
its common stock. The Company does not anticipate any impacts from the new
corporate minimum tax rate since its current tax rate is above the 15% minimum
rate. Further, the Company expects the charges associated with the excise tax to
be recognized in equity consistent with other costs related to treasury stock.

The Company expects that its effective tax rate for future periods will be
approximately 20%. The effective tax rate continues to be subject to future tax
law changes both in the U.S. and in foreign jurisdictions. See the risk factor
entitled "Tax rates applicable to the Company may change" in Item 1A. Risk
Factors of the 2021 Annual Report for more information.

                                       81
--------------------------------------------------------------------------------

Foreign Currency Translation


Aflac Japan's premiums and a significant portion of its investment income are
received in yen, and its claims and most expenses are paid in yen. Aflac Japan
purchases yen-denominated assets and U.S. dollar-denominated assets, which may
be hedged to yen, to support yen-denominated policy liabilities. Yen-denominated
income statement accounts are translated to U.S. dollars using the weighted
average Japanese yen/U.S. dollar foreign exchange rate for the reporting period,
except realized gains and losses on securities transactions which are translated
at the exchange rate on the trade date of each transaction. Yen-denominated
balance sheet accounts are translated to U.S. dollars using the spot Japanese
yen/U.S. dollar foreign exchange rate at the end of the reporting period.

                        RESULTS OF OPERATIONS BY SEGMENT

U.S. GAAP financial reporting requires that a company report financial and
descriptive information about operating segments in its annual and interim
period financial statements. Furthermore, the Company is required to report a
measure of segment profit or loss, certain revenue and expense items, and
segment assets. The Company's insurance business consists of two segments: Aflac
Japan and Aflac U.S. Aflac Japan is the principal contributor to consolidated
earnings. In addition, the Parent Company, other business units that are not
individually reportable, and business activities, including reinsurance
retrocession activities, not included in Aflac Japan or Aflac U.S. are included
in Corporate and other. See Item 1. Business in the 2021 Annual Report for a
summary of each segment's products and distribution channels.

Consistent with U.S. GAAP guidance for segment reporting, pretax adjusted
earnings is the Company's U.S. GAAP measure of segment performance. The Company
believes that a presentation of this measure is vitally important to an
understanding of the underlying profitability drivers and trends of its
business. Additional performance measures used to evaluate the financial
condition and performance of the Company's segments are listed below.


•Operating Ratios
•New Annualized Premium Sales
•New Money Yield
•Return on Average Invested Assets
•Average Weekly Producer

For additional information on the Company's performance measures included in
this MD&A, see the Glossary of Selected Terms found directly following Part II.
Other Information. See Note 2 of the Notes to the Consolidated Financial
Statements for the reconciliation of segment results to the Company's
consolidated U.S. GAAP results and additional information.
                                       82
--------------------------------------------------------------------------------

AFLAC JAPAN SEGMENT

Aflac Japan Pretax Adjusted Earnings


Changes in Aflac Japan's pretax adjusted earnings and profit margins are
primarily affected by morbidity, mortality, expenses, persistency and investment
yields. The following table presents a summary of operating results for Aflac
Japan.

                    Aflac Japan Summary of Operating Results

                                                                     Three Months Ended                     Nine Months Ended
                                                                        September 30,                         September 30,
(In millions)                                                       2022                2021              2022               2021
Net earned premiums                                           $    2,241   

$ 2,934 $ 7,384 $ 9,045
Net investment income: (1)
Yen
-denominated investment income

                                    335                 317                 898              960
U.S. dollar-denominated investment income                            357                 465               1,251            1,355
Net investment income                                                692                 783               2,149            2,315

Amortized hedge costs related to certain foreign currency
exposure management strategies

                                        28                  20                  84               55
Adjusted net investment income                                       663                 763               2,066            2,260
Other income (loss)                                                    9                  10                  26               32
Total adjusted revenues                                            2,913               3,707               9,476           11,337
Benefits and claims, net                                           1,676               1,938               5,133            6,072
Adjusted expenses:
Amortization of deferred policy acquisition costs                    124                 154                 415              496
Insurance commissions                                                132                 175                 435              541
Insurance and other expenses                                         350                 462               1,142            1,360
Total adjusted expenses                                              607                 792               1,991            2,397
Total benefits and adjusted expenses                               2,283               2,731               7,125            8,469
      Pretax adjusted earnings                                $      630   

$ 976 $ 2,351 $ 2,867
Weighted-average yen/dollar exchange rate

                         137.08              110.11              126.65           108.58


                                                                        In Dollars                                                                               In Yen
                                               Three Months Ended                           Nine Months Ended                         Three Months Ended                         Nine Months Ended
Percentage change over                            September 30,                               September 30,                              September 30,                             September 30,
 previous period:                           2022                   2021                 2022                 2021                  2022                  2021                 2022                2021
Net earned premiums                             (23.6) %             (7.4) %              (18.4) %             (4.5) %                 (4.1) %             (4.0) %              (4.2) %             (3.8) %
Adjusted net investment income                  (13.1)               15.1                  (8.6)               16.6                     9.8                19.7                  8.1                17.9
Total adjusted revenues                         (21.4)               (3.5)                (16.4)               (1.0)                   (1.2)                 .1                 (1.7)                (.1)
Pretax adjusted earnings                        (35.5)               30.7                 (18.0)               17.4                   (19.2)               35.8                 (4.0)               18.7


(1) Net interest cash flows from derivatives associated with certain investment
strategies of $(25) and $(7) for the three-month periods and $(37) and $(24) for
the nine-month periods ended September 30, 2022 and 2021, respectively, have
been reclassified from net investment gains (losses) and included in adjusted
earnings as a component of net investment income.

In the three- and nine-month periods ended September 30, 2022, Aflac Japan's net
earned premiums decreased, in yen terms, mainly due to limited-pay products
reaching premium paid-up status and constrained sales from the impact of
pandemic conditions. In yen terms, adjusted net investment income increased in
the three- and nine-month periods ended September 30, 2022, primarily due to the
impact of a weaker yen on U.S. dollar-denominated investment income, a make
whole of a security, and higher floating rate income. The decrease in pretax
adjusted earnings in yen for the three- and nine-month periods ended
September 30, 2022 was primarily due to the increase in the benefit ratio
resulting from a wider scope of "deemed hospitalization" that was in effect
through most of the third quarter.

Annualized premiums in force decreased 4.3% to ¥1.32 trillion as of
September 30, 2022, compared with ¥1.38 trillion as of September 30, 2021. The
decrease in annualized premiums in force in yen was driven primarily by
limited-pay products reaching premium paid-up status and lower sales during the
COVID-19 pandemic. Annualized premiums in force, translated into dollars at
respective period-end exchange rates, were $9.1 billion at September 30, 2022,
compared with $12.3 billion at September 30, 2021.
                                       83
--------------------------------------------------------------------------------


Aflac Japan's investment portfolios include U.S. dollar-denominated securities
and reverse-dual currency securities (yen-denominated debt securities with
dollar coupon payments). In years when the yen strengthens in relation to the
dollar, translating Aflac Japan's U.S. dollar-denominated investment income into
yen lowers growth rates for net investment income, total adjusted revenues, and
pretax adjusted earnings in yen terms. In years when the yen weakens,
translating U.S. dollar-denominated investment income into yen magnifies growth
rates for net investment income, total adjusted revenues, and pretax adjusted
earnings in yen terms.

The following table illustrates the effect of translating Aflac Japan's U.S.
dollar-denominated investment income and related items into yen by comparing
certain segment results with those that would have been reported had foreign
currency exchange rates remained unchanged from the comparable period in the
prior year. Amounts excluding foreign currency impact on U.S. dollar-denominated
investment income were determined using the average foreign currency exchange
rate for the comparable prior year period. See non-U.S. GAAP financial measures
defined above.

              Aflac Japan Percentage Changes Over Previous Period
                            (Yen Operating Results)
                      For the Periods Ended September 30,

                                                               Including Foreign                                                                        Excluding Foreign
                                                               Currency Changes                                                                         Currency Changes
                                        Three Months                                    Nine Months                               Three Months                                   Nine Months
                                    2022                  2021                   2022               2021                   2022                  2021                     2022                 2021
Adjusted net investment
income                            9.8        %         19.7      %             8.1    %             17.9    %              (2.0)       %         17.2    %             (1.6)   %            17.2    %
Total adjusted revenues          (1.2)                   .1                   (1.7)                  (.1)                  (3.6)                  (.3)                 (3.7)                 (.2)
Pretax adjusted earnings        (19.2)                 35.8                   (4.0)                 18.7                  (27.9)                 33.7                 (11.4)                18.2


The following table presents a summary of operating ratios in yen terms for
Aflac Japan.

                                                           Three Months Ended                                    Nine Months Ended
                                                              September 30,                                        September 30,
Ratios to total adjusted revenues:                      2022                        2021                     2022                        2021
Benefits and claims, net                            57.6     %                   52.3    %               54.3            %            53.5    %
Adjusted expenses:
Amortization of deferred policy acquisition
costs                                                4.3                          4.2                     4.4                          4.4
Insurance commissions                                4.5                          4.7                     4.6                          4.8
Insurance and other expenses                        12.0                         12.5                    12.0                         12.0
Total adjusted expenses                             20.8                         21.4                    21.0                         21.2
Pretax adjusted earnings                            21.6                         26.3                    24.7                         25.3
Ratios to total premiums:
Benefits and claims, net                            75.0     %                   66.1    %               69.8     %                   67.1    %
Adjusted expenses:
Amortization of deferred policy acquisition
costs                                                5.5                          5.3                     5.6                          5.5


In the three- and nine-month period ended September 30, 2022, the benefit ratio
to total premiums increased, compared with the same periods in the prior year,
primarily due to a decrease in total premiums and higher third sector benefits
due substantially to an increase in medical hospitalization claims as a result
of a wider scope of "deemed hospitalization" related to COVID-19, partially
offset by the continued change in the mix of first and third sector business. In
the three- and nine-month periods ended September 30, 2022, the adjusted expense
ratio decreased slightly, compared with the same periods in the prior year,
reflecting the decrease in total adjusted revenues and an offsetting decrease in
total adjusted expenses. In total, the pretax adjusted profit margin decreased
in the three- and nine-month periods ended September 30, 2022 primarily due to
lower total adjusted revenues and higher benefit ratios partially offset by
lower expense ratios.

                                       84
--------------------------------------------------------------------------------

Aflac Japan Sales


The following table presents Aflac Japan's new annualized premium sales for the
periods ended September 30.

                                                          In Dollars                                                    In Yen
                                       Three Months                   Nine Months                    Three Months               Nine Months
(In millions of dollars and
billions of yen)                   2022            2021           2022            2021           2022            2021      2022            2021
New annualized premium sales     $  100          $ 114          $  301          $ 371          ¥ 13.9          ¥ 12.6    ¥ 38.5          ¥ 40.2
Increase (decrease) over prior
period                            (12.0) %        (3.8) %        (18.9) %         9.4  %         10.2  %           .0  %   (4.1) %         10.3  %



The following table details the contributions to Aflac Japan's new annualized
premium sales by major insurance product for the periods ended September 30.

                                  Three Months                        Nine Months
                              2022              2021              2022             2021
Cancer                          60.1  %         49.9  %            55.7  %         48.0  %
Medical                         26.4            36.3               29.1            39.9
Income support                   1.2              .5                1.5              .6
Ordinary life:
WAYS                              .6              .7                 .7              .7
Child endowment                   .2              .3                 .2              .3
Other ordinary life (1)          7.7             9.0                8.6             9.1
Other                            3.8             3.3                4.2             1.4
  Total                        100.0  %        100.0  %           100.0  %        100.0  %

(1) Includes term and whole life


The foundation of Aflac Japan's product portfolio has been, and continues to be,
third sector products, which include cancer, medical and income support
insurance products. Aflac Japan has been focusing more on promotion of cancer
and medical insurance products in this low-interest-rate environment. These
products are less interest-rate sensitive and more profitable compared to first
sector savings products. With continued cost pressure on Japan's health care
system, the Company expects the need for third sector products will continue to
rise in the future and that the medical and cancer insurance products Aflac
Japan provides will continue to be an important part of its product portfolio.

Sales of protection-type first sector and third sector products on a yen basis
increased 10.5% in the third quarter of 2022, compared with the third quarter of
2021, reflecting the August 2022 launch of a new cancer insurance product
through the agency channel.

Sales of Aflac Japan cancer products in the Japan Post Group channel experienced
a material decline beginning in August 2019. Japan Post Group resumed proactive
sales of cancer insurance policies in April 2021 and Aflac Japan continues to
strengthen the strategic alliance. In April 2022, approximately 10,000 employees
of Japan Post Co. were transferred to Japan Post Insurance. Japan Post Group has
informed Aflac Japan that the transferred employees' responsibilities will
include sales of Japan Post Insurance products and Aflac Japan cancer products
but will not include sales of other financial products. The Company expects
continued collaboration to further position both companies for long-term growth
and a gradual improvement of Japan Post Group cancer insurance sales in the
intermediate term. For example, in 2021 and the first nine months of 2022, Aflac
Japan observed an increase in the number of proposals to potential customers in
the Japan Post Group channel, and the Japan Post Group continues to conduct a
nationwide campaign to improve certain sales process practices. For additional
information, see the risk factor entitled "Sales of the Company's products and
services are dependent on its ability to attract, retain and support a network
of qualified sales associates, brokers and employees in the U.S. and sales
associates and other distribution partners in Japan," in Item 1A. Risk Factors
in the 2021 Annual Report.

In response to the COVID-19 pandemic, Aflac Japan continues to promote digital
and web-based sales to groups and use of its system that enables smart
device-based insurance application by allowing the customer and an Aflac Japan
operator to see the same screen through their smart devices. Further, Aflac
Japan continues to utilize its virtual sales tool that enables online
consultations and policy applications to be completed entirely online.

                                       85
--------------------------------------------------------------------------------

The following table details the contributions to Aflac Japan's new annualized
premium sales by agency type for the three-month periods ended September 30.


                                         2022         2021
Independent corporate and individual     49.3  %      49.9  %
Affiliated corporate (1)                 46.2         43.8
Bank                                      4.5          6.3
Total                                   100.0  %     100.0  %

(1) Includes Japan Post Group


During the three-month period ended September 30, 2022, Aflac Japan recruited 12
new sales agencies. At September 30, 2022, Aflac Japan was represented by
approximately 7,500 sales agencies, with approximately 110,000 licensed sales
associates employed by those agencies. The number of sales agencies has declined
in recent years due to Aflac Japan's focus on supporting agencies with strong
management frameworks, high productivity and more producing agents.

At September 30, 2022, Aflac Japan had agreements to sell its products at 359
banks, approximately 90% of the total number of banks in Japan.

Aflac Japan Investments


The level of investment income in yen is affected by available cash flow from
operations, the timing of investing the cash flow, yields on new investments,
the effect of yen/dollar exchange rates on U.S. dollar-denominated investment
income, and other factors.

As part of the Company's portfolio management and asset allocation process,
Aflac Japan invests in yen and U.S. dollar-denominated investments.
Yen-denominated investments primarily consist of JGBs, public and private fixed
maturity securities and public equity securities. Aflac Japan's U.S.
dollar-denominated investments include fixed maturity investments and growth
assets, including alternative investments in limited partnerships or similar
investment vehicles. Aflac Japan has been investing in both publicly-traded and
privately originated U.S. dollar-denominated investment-grade and
below-investment-grade fixed maturity securities and loan receivables, and has
entered into foreign currency forwards and options to hedge the currency risk on
the fair value of a portion of the U.S. dollar investments.

                                       86
--------------------------------------------------------------------------------

The following table details the investment purchases for Aflac Japan.

                                                             Three Months Ended September               Nine Months Ended September
                                                                          30,                                       30,
(In millions)                                                    2022              2021                    2022              2021
Yen-denominated:
 Fixed maturity securities:
   Japan government and agencies                             $       0          $     0                $       0          $ 1,181
   Private placements                                               70              146                      842              456
   Other fixed maturity securities                                  29               25                       66              161
 Equity securities                                                  82               75                      358              197
 Other investments                                                   9                3                       13                8
    Total yen-denominated                                    $     190          $   249                $   1,279          $ 2,003

U.S. dollar-denominated:
 Fixed maturity securities:
   Other fixed maturity securities                           $      86          $   363                $     420          $ 1,362
   Infrastructure debt                                             182                0                      296                0

   Collateralized loan obligations                                   0               40                      498              194
 Equity securities                                                   0                0                       22                8

Commercial mortgage and other loans:

   Transitional real estate loans                                  255              390                    1,540            1,089
   Commercial mortgage loans                                         0                0                        0               17
   Middle market loans                                             333              496                    1,007            1,762
 Other investments                                                 100               94                      283              241
    Total U.S. dollar-denominated                            $     956          $ 1,383                $   4,066          $ 4,673
      Total Aflac Japan purchases                            $   1,146          $ 1,632                $   5,345          $ 6,676



See the Investments section of this MD&A for further discussion of these
investment programs, and see Notes 3 and 4 of the Notes to the Consolidated
Financial Statements and Notes 1, 3 and 4 of the Notes to the Consolidated
Financial Statements in the 2021 Annual Report for more information regarding
loans and loan receivables.

The following table presents the results of Aflac Japan's investment yields for
the periods ended September 30.


                                                                        Three Months                                Nine Months
                                                                 2022                   2021                   2022                   2021
Total purchases for the period (in millions) (1)           $ 1,037                $ 1,535                $ 5,049                $ 6,427
New money yield (1), (2)                                      5.73        % 

3.99 % 4.16 % 3.38 %
Return on average invested assets (3)

                         2.87                   2.72                   2.79                   2.68

Portfolio book yield, including U.S. dollar-denominated
investments, end of period (1)

                                2.91        % 

2.60 % 2.91 % 2.60 %



(1) Includes fixed maturity securities, commercial mortgage and other loans,
equity securities, and excludes alternative investments in limited partnerships
(2) Reported on a gross yield basis; excludes investment expenses, external
management fees, and amortized hedge costs
(3) Net of investment expenses and amortized hedge costs, year-to-date number
reflected on a quarterly average basis

The increase in the Aflac Japan new money yield in the three- and nine-month
periods ended September 30, 2022 was primarily due to increases in U.S. interest
rates. See Notes 3, 4 and 5 of the Notes to the Consolidated Financial
Statements and the Investments and Hedging Activities sections of this MD&A for
additional information on the Company's investments and hedging strategies.

                                       87
--------------------------------------------------------------------------------

AFLAC U.S. SEGMENT

Aflac U.S. Pretax Adjusted Earnings


Changes in Aflac U.S. pretax adjusted earnings and profit margins are primarily
affected by morbidity, mortality, expenses, persistency and investment yields.
The following table presents a summary of operating results for Aflac U.S.

                    Aflac U.S. Summary of Operating Results

                                                              Three Months Ended                      Nine Months Ended
                                                                 September 30,                          September 30,
(In millions)                                                2022                2021               2022               2021
Net earned premiums                                    $    1,375             $ 1,393           $    4,182          $ 4,223
Adjusted net investment income (1)                            185                 191                  563              557
Other income                                                   38                  32                  120               90
Total adjusted revenues                                     1,598               1,616                4,865            4,870
Benefits and claims                                           621                 628                1,876            1,798
Adjusted expenses:
Amortization of deferred policy acquisition costs             144                 123                  443              373
Insurance commissions                                         135                 136                  411              411
Insurance and other expenses                                  390                 370                1,152            1,071
Total adjusted expenses                                       668                 629                2,006            1,855
Total benefits and adjusted expenses                        1,289               1,257                3,882            3,653
       Pretax adjusted earnings                        $      309             $   358           $      984          $ 1,217
Percentage change over previous period:
Net earned premiums                                          (1.3)          %    (1.0)   %            (1.0)   %        (2.9)   %
Adjusted net investment income                               (3.1)                9.1                  1.1              6.5
Total adjusted revenues                                      (1.1)                 .6                  (.1)            (1.6)
Pretax adjusted earnings                                    (13.7)                8.8                (19.1)            12.5


(1) Net interest cash flows from derivatives associated with certain investment
strategies of $(1) and $1 for the three-month periods and $1 and $1 for the
nine-month periods ended September 30, 2022 and 2021, respectively, have been
reclassified from net investment gains (losses) and included in adjusted
earnings as a component of net investment income.

In the three- and nine-month periods ended September 30, 2022, net earned
premiums for Aflac U.S. decreased primarily due to lower persistency. Adjusted
net investment income decreased in the three-month period ended September 30,
2022 due to lower variable net investment income, offset by higher floating rate
income and increased in the nine-month period ended September 30, 2022,
primarily due to higher floating rate income due to higher volumes and rates.
Other income increased in the three- and nine-month periods ended September 30,
2022 due to an increase in fee income. The decrease in pretax adjusted earnings
in the three- and nine-month periods ended September 30, 2022 was driven
primarily by higher DAC amortization associated with lower persistency and
planned spending reflecting, in part, platform and growth investments.

Annualized premiums in force were $5.9 billion at September 30, 2022 and 2021,
respectively.

                                       88
--------------------------------------------------------------------------------

The following table presents a summary of operating ratios for Aflac U.S.


                                                               Three Months Ended                                     Nine Months Ended
                                                                  September 30,                                         September 30,
Ratios to total adjusted revenues:                          2022                         2021                     2022                         2021
Benefits and claims                                     38.9     %                    38.9    %               38.6     %                    36.9    %
Adjusted expenses:
Amortization of deferred policy acquisition costs        9.0                           7.6                     9.1                           7.7
Insurance commissions                                    8.4                           8.4                     8.4                           8.4
Insurance and other expenses                            24.4                          22.9                    23.7                          22.0
Total adjusted expenses                                 41.8                          38.9                    41.2                          38.1
 Pretax adjusted earnings                               19.3                          22.2                    20.2                          25.0
Ratios to total premiums:
Benefits and claims                                     45.2     %                    45.1    %               44.9     %                    42.6    %
Adjusted expenses:
Amortization of deferred policy acquisition costs       10.5                           8.8                    10.6                           8.8



For the three-month period ended September 30, 2022, the benefit ratio to total
premiums increased slightly compared with the same period in 2021. For the
nine-month period ended September 30, 2022, the benefit ratio to total premiums
increased compared with the same period in 2021, reflecting higher incurred
claims, partially offset by reserve releases related to lower persistency. The
adjusted expense ratio increased in the three- and nine-month periods ended
September 30, 2022, when compared with the same periods in 2021, primarily due
to higher DAC amortization associated with lower persistency and planned
spending reflecting ongoing investments in the U.S. platform. The pretax
adjusted profit margin decreased in the three- and nine-month periods ended
September 30, 2022, compared with the same periods in 2021, primarily due to the
higher adjusted expense and benefit ratios.

Aflac U.S. Sales

The following table presents Aflac's U.S. new annualized premium sales for the
periods ended September 30.


                                                   Three Months                         Nine Months
(In millions)                                  2022                 2021          2022             2021
New annualized premium sales              $    334               $ 299          $  938          $ 814
Increase (decrease) over prior period         11.8        %       35.0   %  

15.2 % 15.5 %




New annualized premium sales for accident insurance decreased .9%; disability
sales increased 23.0%; critical care insurance sales (including cancer
insurance) increased 6.3%; hospital indemnity insurance sales increased 4.6%;
and dental/vision sales increased 42.7% in the third quarter of 2022, compared
with the third quarter of 2021. The increase in sales for Aflac U.S. in the
third quarter of 2022 reflects continued improvement from investment in growth
initiatives as well as productivity gains. For the full year of 2022, Aflac U.S.
expects this trend of increasing sales to continue.

The following table details the contributions to Aflac's U.S. new annualized
premium sales by major insurance product category for the periods ended
September 30.

                                Three Months                             Nine Months
                          2022                  2021               2022                 2021
Accident               22.6    %             25.5    %          24.1    %             26.3   %
Disability             28.9                  26.2               25.9                  24.1
 Critical care(1)      18.1                  19.1               19.9                  20.8
Hospital indemnity     14.1                  15.1               15.2                  16.0
Dental/vision           6.3                   4.9                6.1                   5.0
Life                   10.0                   9.2                8.8                   7.8
Total                 100.0    %            100.0    %         100.0        %        100.0     %

(1) Includes cancer, critical illness, and hospital intensive care products

                                       89
--------------------------------------------------------------------------------

In the third quarter of 2022, the Aflac U.S. sales force included an average of
approximately 6,000 U.S. agents, including brokers, who were actively producing
business on a weekly basis. The Company believes that this average weekly
producer equivalent metric allows sales management to monitor progress and
needs, as well as serve as a leading indicator of future production capacity.
Aflac U.S. believes that during 2021 and continuing into 2022, constraints in
the labor market have limited its recruiting of new sales agents, and that
limitations on face-to-face sales opportunities during the COVID-19 pandemic
suppressed the development of newly recruited agents into business producers and
the productivity of veteran agents and brokers. Aflac U.S. believes that the
above factors have acted as a headwind to sales and to growth in the number of
average weekly producers. Aflac U.S. remains focused on mitigating and reversing
these trends as the U.S. economy continues to recover from the pandemic.

In response to the COVID-19 pandemic, Aflac U.S. remains focused on supporting
its agency channel, most of which are small businesses, by offering financial
support and an extended value proposition. The Aflac U.S. sales team has pivoted
to accommodate preferred enrollment conditions which include realizing sales at
the worksite through in-person enrollment, an enrollment call center, video
enrollment through co-browsing and self-enrollment. The traditional agent sales
team is also using virtual recruiting and training through video conferencing in
order to maintain or increase the recruiting pipeline. The Aflac U.S. broker
sales team is focused on product enhancements due to COVID-19 as well as
leveraging technology based solutions to drive enrollment.

Aflac U.S. Investments

The level of investment income is affected by available cash flow from
operations, the timing of investing the cash flow, yields on new investments,
and other factors.


As part of the Company's portfolio management and asset allocation process,
Aflac U.S. invests in fixed maturity investments and growth assets, including
public equity securities and alternative investments in limited partnerships.
Aflac U.S. has been investing in both publicly traded and privately originated
investment-grade and below-investment-grade fixed maturity securities and loan
receivables.

The following table details the investment purchases for Aflac U.S.

                                                  Three Months Ended               Nine Months Ended
                                                     September 30,                   September 30,
  (In millions)                                     2022             2021          2022          2021
  Fixed maturity securities:
     Other fixed maturity securities        $      138              $ 141      $      477      $   517
     Infrastructure debt                           104                 30             123           30
     Collateralized loan obligations                 0                 22             199           52
  Equity securities                                  4                 91              23          203
  Other investments:
     Transitional real estate loans                125                109             310          245
     Commercial mortgage loans                       0                  0               0          163
     Middle market loans                            56                 37             262          138
     Limited partnerships                           11                 10              32           27
      Total Aflac U.S. Purchases            $      438              $ 440      $    1,426      $ 1,375


See Note 3 of the Notes to the Consolidated Financial Statements and Notes 1 and
3 of the Notes to the Consolidated Financial Statements in the 2021 Annual
Report for more information regarding loans and loans receivables.

                                       90
--------------------------------------------------------------------------------

The following table presents the results of Aflac's U.S. investment yields for
the periods ended September 30.


                                                                Three Months                                    Nine Months
                                                       2022                      2021                   2022                    2021
Total purchases for period (in millions) (1)      $    427                     $ 430                 $ 1,394                 $ 1,348
New money yield (1), (2)                              6.24        %             3.87    %               4.90         %          3.59        %
Return on average invested assets (3)                 4.57                      4.88                    4.74                    4.84
Portfolio book yield, end of period (1)               5.21             %    

5.04 % 5.21 % 5.04 %



(1) Includes fixed maturity securities, commercial mortgage and other loans,
equity securities, and excludes alternative investments in limited partnerships
(2) Reported on a gross yield basis; excludes investment expenses and external
management fees
(3) Net of investment expenses, year-to-date number reflected on a quarterly
average basis

The increase in the Aflac U.S. new money yield in the three- and nine-month
periods ended September 30, 2022 was primarily due to increases in U.S. interest
rates. See Notes 3 and 5 of the Notes to the Consolidated Financial Statements
and the Investments section of this MD&A for additional information on the
Company's investments.

CORPORATE AND OTHER


Changes in the pretax adjusted earnings of Corporate and other are primarily
affected by investment income. The following table presents a summary of results
for Corporate and other.

                Corporate and Other Summary of Operating Results

                                                          Three Months Ended                      Nine Months Ended
                                                             September 30,                          September 30,
(In millions)                                            2022              2021                 2022                2021
Net earned premiums                                  $       35          $   45           $      112              $  138
Net investment income (loss) (1)                             16              11                   11                  14
Amortized hedge income related to certain foreign
currency management strategies                               19              13                   44                  45
Adjusted net investment income                               35              24                   55                  59
Other income                                                  3               3                   22                   8
Total adjusted revenues                                      73              72                  189                 205
Benefits and claims, net                                     43              42                  116                 126
Adjusted expenses:
Interest expense                                             44              39                  123                 126
Other adjusted expenses                                      45              32                  129                  97
Total adjusted expenses                                      89              71                  252                 223
Total benefits and adjusted expenses                        132             113                  368                 349
Pretax adjusted earnings                             $      (59)         $  (41)          $     (179)             $ (144)


(1) The change in value of federal historic rehabilitation and solar investments
in partnerships of $19 and $5 for the three-month periods and $61 and $35 for
the nine-month periods ended September 30, 2022, and 2021, respectively, is
included as a reduction to net investment income. Tax credits on these
investments of $19 and $10 for the three-month periods and $63 and $35 for the
nine-month periods ended September 30, 2022, and 2021, respectively, have been
recorded as an income tax benefit in the consolidated statement of earnings. See
Note 3 of the Notes to the Consolidated Financial Statements for additional
information on these investments.

In the three-month period ended September 30, 2022, total adjusted revenues
increased slightly, compared to the same period in 2021, primarily due to higher
adjusted net investment income from higher interest rates and an increase in
amortized hedge income, partially offset by the impact of federal tax credit
investments and a reduction in net earned premiums as a result of significant
yen weakening. In the nine-month period ended September 30, 2022, total adjusted
revenues decreased compared to the same period in 2021, reflecting a reduction
in net earned premiums, lower adjusted net investment income from lower
amortized hedge income and the impact of federal tax credit investments. These
results also reflect the impact of foreign currency on total net earned premiums
and the corresponding benefits. Pretax adjusted earnings decreased in the three-
and nine-month periods ended September 30, 2022 when compared to the same
periods in 2021.

                                       91
--------------------------------------------------------------------------------

The Parent Company invests in partnerships that specialize in rehabilitating
historic structures or the installation of solar equipment in order to receive
federal historic rehabilitation and solar tax credits. These investments are
classified as limited partnerships and included in other investments in the
consolidated balance sheet. The change in value of each investment is recorded
as a reduction to net investment income. Tax credits generated by these
investments are recorded as an income tax benefit in the consolidated statement
of earnings.

                                  INVESTMENTS

The Company's investment strategy utilizes disciplined asset and liability
management while seeking long-term risk-adjusted investment returns and the
delivery of stable income within regulatory and capital objectives, and
preserving shareholder value. In attempting to optimally balance these
objectives, the Company seeks to maintain on behalf of Aflac Japan a diversified
portfolio of yen-denominated investment assets, U.S. dollar-denominated
investment portfolio hedged back to yen and a portfolio of unhedged U.S.
dollar-denominated assets. As part of the Company's portfolio management and
asset allocation process, Aflac U.S. invests in fixed maturity investments and
growth assets, including public equity securities and alternative investments in
limited partnerships. Aflac U.S. invests in both publicly traded and privately
originated investment-grade and below-investment-grade fixed maturity securities
and loans. Additionally, in November 2021, the Company became a signatory to the
Principles for Responsible Investment, a global framework for incorporating
environmental, social and governance (ESG) considerations into investment and
ownership decisions.

For additional information concerning the Company's investments, see Notes 3, 4,
and 5 of the Notes to the Consolidated Financial Statements.

The following tables detail investments by segment.

                        Investment Securities by Segment

                                                                     September 30, 2022
                                                                                    Corporate and
(In millions)                            Aflac Japan            Aflac U.S.              Other                Total
Available for sale, fixed maturity
securities,
  at fair value                        $     59,894           $    11,909           $     1,840           $  73,643
Held to maturity, fixed maturity
securities,
  at amortized cost (1)                      17,466                     0                     0              17,466
Equity securities                               584                    63                   417               1,064
Commercial mortgage and other loans:
Transitional real estate loans (1)            5,090                 1,176                   181               6,447
Commercial mortgage loans (1)                 1,278                   724                    15               2,017
Middle market loans (1)                       4,537                   458                     0               4,995
Other investments:
Policy loans                                    172                    23                     0                 195
Short-term investments (2)                      694                   187                   935               1,816
Limited partnerships                          1,804                   199                   142               2,145
Other                                             0                    30                     0                  30
   Total investments                         91,519                14,769                 3,530             109,818
Cash and cash equivalents                     1,488                   492                 2,730               4,710
       Total investments and cash      $     93,007           $    15,261           $     6,260           $ 114,528


(1) Net of allowance for credit losses
(2) Includes securities lending collateral

                                       92
--------------------------------------------------------------------------------
                                                                      December 31, 2021
                                                                                    Corporate and
(In millions)                            Aflac Japan            Aflac U.S.              Other                Total
Available for sale, fixed maturity
securities,
  at fair value                        $     81,793           $    14,910           $     1,993           $  98,696
Held to maturity, fixed maturity
securities,
  at amortized cost (1)                      22,000                     0                     0              22,000
Equity securities                               714                   226                   663               1,603
Commercial mortgage and other loans:
Transitional real estate loans (1)            4,226                 1,020                    45               5,291
Commercial mortgage loans (1)                 1,217                   669                     8               1,894
Middle market loans (1)                       4,297                   304                     0               4,601
Other investments:
Policy loans                                    216                    20                     0                 236
Short-term investments (2)                      590                   302                   834               1,726
Limited partnerships                          1,534                   169                   155               1,858
Other                                             0                    22                     0                  22
   Total investments                        116,587                17,642                 3,698             137,927
Cash and cash equivalents                     2,053                   681                 2,317               5,051
       Total investments and cash      $    118,640           $    18,323           $     6,015           $ 142,978


(1) Net of allowance for credit losses
(2) Includes securities lending collateral

The ratings of the Company's securities referenced in the table below are based
on the ratings designations provided by major rating organizations such as
Moody's, Standard & Poor's and Fitch or, if not rated, are determined based on
the Company's internal analysis of such securities. When the ratings issued by
the rating agencies differ, the Company utilizes the second lowest rating when
three or more rating agency ratings are available or the lowest rating when only
two rating agency ratings are available.

The distributions of fixed maturity securities the Company owns, by credit
rating, were as follows:


           Composition of Fixed Maturity Securities by Credit Rating

                              September 30, 2022                                     December 31, 2021
                      Amortized                    Fair                     Amortized                    Fair
                        Cost                       Value                       Cost                      Value
AAA                           1.6  %                    1.5  %                      1.0  %                     .9  %
AA                            5.4                       5.6                         5.1                       5.2
A                            67.6                      67.7                        68.9                      68.5
BBB                          23.0                      22.8                        22.5                      22.8
BB or lower                   2.4                       2.4                         2.5                       2.6
Total                       100.0  %                  100.0  %                    100.0  %                  100.0  %


As of September 30, 2022, the Company's direct and indirect exposure to
securities in its investment portfolio that were guaranteed by third parties was
immaterial both individually and in the aggregate.

                                       93
--------------------------------------------------------------------------------

The following table presents the 10 largest unrealized loss positions in the
Company's portfolio as of September 30, 2022.


                                 Credit            Amortized            

Fair

(In millions)                    Rating              Cost               Value            Unrealized Loss
JP Morgan Chase and Co.              A                $ 197            $ 160                       $ (37)
Investcorp Capital Limited          BB                  305              273                         (32)
Autostrade Per Litalia Spa          BB                  137              106                         (31)
KLM Royal Dutch Airlines             B                  122               93                         (29)
Banco de Chile                       A                  138              112                         (26)
Oracle Corp                         BBB                 173              148                         (25)
Prologis LP                          A                  159              136                         (23)
AXA                                 BBB                 235              215                         (20)
Morgan Stanley                       A                  124              104                         (20)
GLP Pte Ltd.                        BBB                 104               85                         (19)



Generally, declines in fair values can be a result of changes in interest rates,
yen/dollar exchange rate, and changes in net spreads driven by a broad market
move or a change in the issuer's underlying credit quality. The Company believes
these issuers have the ability to continue making timely payments of principal
and interest. See the Unrealized Investment Gains and Losses section in Note 3
of the Notes to the Consolidated Financial Statements for further discussions of
unrealized losses related to financial institutions and other corporate
investments.

Below-Investment-Grade Securities

The Company's portfolio of below-investment-grade securities includes debt
securities purchased while the issuer was rated investment grade plus other
loans and bonds purchased as part of an allocation to that segment of the
market. The following is the Company's below-investment-grade exposure.


                       Below-Investment-Grade Investments

                                                         September 30, 2022
                                                                                  Unrealized
                                          Par        Amortized        Fair           Gain
(In millions)                            Value        Cost (1)        Value         (Loss)
Investcorp Capital Limited             $   306      $      305      $   273      $      (32)
Pemex Project Funding Master Trust         207             207          208               1
Commerzbank                                173             131          183              52
KLM Royal Dutch Airlines                   138             122           93             (29)
Telecom Italia SpA                         138             138          163              25
Autostrade Per Litalia Spa                 138             137          106             (31)
Apache Corporation                         138             104          126              22
Howmet Aerospace Inc.                      100              64           90              26
IKB Deutsche Industriebank AG               90              43           69              26
Generalitat de Catalunya                    55              22           55              33
Other Issuers                              193             187          165             (22)
     Subtotal (2)                        1,676           1,460        1,531              71

High yield corporate bonds                 785             620          675              55
Middle market loans                      4,710           4,555        4,558               3
     Grand Total                       $ 7,171      $    6,635      $ 6,764      $      129


(1) Net of allowance for credit losses
(2) Securities initially purchased as investment grade, but have subsequently
been downgraded to below investment grade

The Company invests in middle market loans primarily to U.S. corporate
borrowers, most of which have below-investment-grade ratings. The objectives of
this program include enhancing the yield on invested assets, achieving further
diversification of credit risk, and mitigating the risk of rising interest rates
and hedge costs through the acquisition of floating rate assets.

                                       94
--------------------------------------------------------------------------------

The Company maintains an allocation to higher yielding corporate bonds within
the Aflac Japan and Aflac U.S. portfolios. Most of these securities were rated
below-investment-grade at the time of purchase, but the Company also purchased
several that were rated investment grade which, because of market pricing, offer
yields commensurate with below-investment-grade risk profiles. The objective of
this allocation was to enhance the Company's yield on invested assets and
further diversify credit risk. All investments in this program must have a
minimum rating at purchase of low BB using the Company's above described rating
methodology and are managed by the Company's internal credit portfolio
management team.

Fixed Maturity Securities by Sector

The Company maintains diversification in investments by sector to avoid
concentrations to any one sector, thus managing exposure risk. The following
table shows the distribution of fixed maturities by sector classification.

                                                                                                 September 30, 2022
                                                                                                         Gross
                                                                             Gross Unrealized         Unrealized                                      % of
(In millions)                                   Amortized Cost (1)                Gains                 Losses              Fair Value                Total
Government and agencies                     $                40,260          $       4,041          $     (1,166)         $    43,135                      45.4  %
Municipalities                                                2,463                    279                  (145)               2,597                       2.8
Mortgage- and asset-backed securities                         1,963                    128                   (82)               2,009                       2.2
Public utilities                                              7,037                    622                  (268)               7,391                       8.0
Electric                                                      5,718                    511                  (191)               6,039                       6.5
Natural Gas                                                     229                     33                   (10)                 251                        .3
Other                                                           532                     40                   (42)                 529                        .6
Utility/Energy                                                  558                     38                   (25)                 572                        .6
Sovereign and Supranational                                   1,206                    147                   (14)               1,339                       1.3
Banks/financial institutions                                  8,815                    712                  (496)               9,031                      10.0
Banking                                                       5,196                    489                  (290)               5,395                       5.9
Insurance                                                     1,702                    147                   (70)               1,780                       1.9
Other                                                         1,917                     76                  (136)               1,856                       2.2
Other corporate                                              26,757                  2,852                (1,383)              28,226                      30.3
Basic Industry                                                2,358                    296                  (107)               2,546                       2.7
Capital Goods                                                 3,147                    269                  (195)               3,222                       3.6
Communications                                                2,711                    346                   (90)               2,967                       3.1
Consumer Cyclical                                             2,174                    243                   (68)               2,349                       2.5
Consumer Non-Cyclical                                         5,988                    582                  (322)               6,247                       6.7
Energy                                                        2,550                    379                   (91)               2,838                       2.9
Other                                                         1,263                    108                   (88)               1,284                       1.4
Technology                                                    3,573                    237                  (233)               3,578                       4.0
Transportation                                                2,993                    392                  (189)               3,195                       3.4
    Total fixed maturity securities         $                88,501          $       8,781          $     (3,554)         $    93,728                   

100.0 %

(1) Net of allowance for credit losses

Securities by Type of Issuance


The Company has investments in both publicly and privately issued securities.
The Company's ability to sell either type of security is a function of overall
market liquidity which is impacted by, among other things, the amount of
outstanding securities of a particular issuer or issuance, trading history of
the issue or issuer, overall market conditions, and idiosyncratic events
affecting the specific issue or issuer.

                                       95
--------------------------------------------------------------------------------

The following table details investment securities by type of issuance.

                   Investment Securities by Type of Issuance

                                             September 30, 2022                        December 31, 2021
                                       Amortized              Fair               Amortized              Fair
(In millions)                           Cost (1)             Value               Cost (1)              Value
Publicly issued securities:
Fixed maturity securities             $   72,693            $ 76,937            $  88,552            $ 103,034
Equity securities                            854                 854                  950                  950
   Total publicly issued                  73,547              77,791               89,502              103,984
Privately issued securities: (2)
Fixed maturity securities (3)             15,808              16,791               18,817               22,531
Equity securities                            210                 210                  653                  653
   Total privately issued                 16,018              17,001               19,470               23,184
   Total investment securities        $   89,565            $ 94,792            $ 108,972            $ 127,168

(1) Net of allowance for credit losses
(2) Primarily consists of securities owned by Aflac Japan (3) Excludes Rule 144A securities

The following table details the Company's reverse-dual currency securities.

                      Reverse-Dual Currency Securities(1)

                                                                 September 30,                      December 31,
(Amortized cost, in millions)                                         2022                              2021
Privately issued reverse-dual currency securities                    $ 3,707                           $ 4,784

Publicly issued collateral structured as reverse-dual
currency securities

                                                    1,267                             1,596
Total reverse-dual currency securities                               $ 4,974                           $ 6,380
Reverse-dual currency securities as a percentage of total
investment
  securities                                                             5.6  %                            5.9  %

(1) Principal payments in yen and interest payments in dollars


Aflac Japan has a portfolio of privately issued securities to better match
liability characteristics and secure higher yields than those available on
Japanese government or other public corporate bonds. Aflac Japan's investments
in yen-denominated privately issued securities consist primarily of non-Japanese
issuers, are rated investment grade at purchase and have longer maturities,
thereby allowing the Company to improve asset/liability matching and overall
investment returns. These securities are generally either privately negotiated
arrangements or issued under medium-term note programs and have standard
documentation commensurate with credit ratings of the issuer, except when
internal credit analysis indicates that additional protective and/or event-risk
covenants were required. Many of these investments have protective covenants
appropriate to the specific investment. These may include a prohibition of
certain activities by the borrower, maintenance of certain financial measures,
and specific conditions impacting the payment of the Company's notes.

                               HEDGING ACTIVITIES

The Company uses derivative contracts to hedge foreign currency exchange rate
risk and interest rate risk. The Company uses various strategies, including
derivatives, to manage these risks. See Item 7A. Quantitative and Qualitative
Disclosures About Market Risk in the 2021 Annual Report for more information
about market risk and the Company's use of derivatives.

Derivatives are designed to reduce risk on an economic basis while minimizing
the impact on financial results. The Company's derivatives programs vary
depending on the type of risk being hedged. See Note 4 of the Notes to the
Consolidated Financial Statements for:


•A description of the Company's derivatives, hedging strategies and underlying
risk exposure.
•Information about the notional amount and fair market value of the Company's
derivatives.
                                       96
--------------------------------------------------------------------------------

•The unrealized and realized gains and losses impact on adjusted earnings of
derivatives in cash flow, fair value, net investments in foreign operations, or
non-qualifying hedging relationships.

Foreign Currency Exchange Rate Risk Hedge Program

The Company has deployed the following hedging strategies to mitigate exposure
to foreign currency exchange rate risk:

•Aflac Japan hedges U.S. dollar-denominated investments back to yen (see Aflac
Japan's
U.S. Dollar-Denominated Hedge Program below).

•Aflac Japan maintains certain unhedged U.S. dollar-denominated securities,
which serve as an economic currency hedge of a portion of the Company's
investment in Aflac Japan (see Aflac Japan's U.S. Dollar-Denominated Hedge
Program below).

•The Parent Company designates yen-denominated liabilities (notes payable and
loans) as non-derivative hedging instruments and designates certain foreign
currency forwards and options as derivative hedges of the Company's net
investment in Aflac Japan (see Enterprise Corporate Hedging Program below).


•The Parent Company enters into forward and option contracts to accomplish a
dual objective of hedging foreign currency exchange rate risk related to
dividend payments by its subsidiary, ALIJ, and reducing enterprise-wide hedge
costs. (see Enterprise Corporate Hedging Program below).

The following table presents metrics related to Aflac Japan's U.S.
dollar-denominated hedge program and the Parent Company's enterprise corporate
hedging program, including associated amortized hedge costs/income, for the
periods ended September 30. See the Results of Operations section of this MD&A
for the Company's definition of amortized hedge costs/income.

                                                               Three Months                            Nine Months
                                                           2022                2021             2022                 2021
Aflac Japan:
FX Forwards

FX forward (sell USD, buy yen) notional at end of
period (in billions) (1)

                                   $4.1                $6.4             $4.1                 $6.4
  Weighted average remaining tenor (in months) (2)         3.7                 3.7               3.7                 3.7
  Amortized hedge income (cost) for period (in
millions)                                                 $(10)               $(13)             $(36)               $(42)

FX Options
FX option notional at the end of period (in billions)
(1)

                                                       $13.5                $8.0             $13.5                $8.0
Weighted average remaining tenor (in months) (2)           3.2                 3.6               3.2                 3.6
Amortized hedge income (cost) for period (in millions)    $(18)                $(7)             $(48)               $(13)
Corporate and Other (Parent Company):
FX Forwards

FX forward (buy USD, sell yen) notional at end of
period (in billions) (1)

                                   $5.0                $5.0             $5.0                 $5.0
  Weighted average remaining tenor (in months) (2)         11.9                12.2             11.9                 12.2
  Amortized hedge income (cost) for period (in
millions)                                                  $20                 $14               $46                 $49

FX Options
FX option notional at the end of period (in billions)
(1)

                                                        $1.7                $2.0             $1.7                 $2.0
Weighted average remaining tenor (in months) (2)           6.1                 7.2               6.1                 7.2
Amortized hedge income (cost) for period (in millions)     $(1)                $(1)             $(2)                 $(4)


(1) Notional is reported net of any offsetting positions within Aflac Japan or
the Parent Company, respectively.
(2) Tenor based on period reporting date to settlement date

Amortized hedge costs/income can fluctuate based upon many factors, including
the derivative notional amount, the length of time of the derivative contract,
changes in both U.S. and Japan interest rates, and supply and demand for dollar
funding. Amortized hedge costs/income have fluctuated in recent periods due to
changes in the previously mentioned factors.

                                       97
--------------------------------------------------------------------------------

Aflac Japan's U.S. Dollar-Denominated Hedge Program (U.S. Dollar Program)


Aflac Japan buys U.S. dollar-denominated investments, typically corporate bonds,
and hedges them back to yen with foreign currency forwards and options to hedge
foreign currency exchange rate risk. This economically creates yen assets that
match yen liabilities during the life of the derivative and provides favorable
capital treatment under the Japan solvency margin ratio (SMR) calculations. The
currency risk being hedged is generally based on fair value of hedged
investments. The following table summarizes the U.S. dollar-denominated
investments held by Aflac Japan.

                                                             September 30,                         December 31,
                                                                  2022                                 2021
                                                      Amortized            Fair            Amortized            Fair
(In millions)                                          Cost (1)            Value            Cost (1)            Value

Available-for-sale securities:

 Fixed maturity securities                           $  13,845          $ 15,780          $  17,615          $ 20,478

Equity securities                                           40                40                 24                24

Commercial mortgage and other loans:

 Transitional real estate loans (floating rate)          5,090             5,044              4,226             4,293
 Commercial mortgage and other loans                     1,278             1,140              1,217             1,265
 Middle market loans (floating rate)                     4,536             4,533              4,297             4,352
Other investments                                        1,805             1,805              1,534             1,534
   Total U.S. Dollar Program                            26,594            28,342             28,913            31,946

Available-for-sale securities:

Fixed maturity securities - economically converted
to yen

                                                   2,015             2,689              2,236             3,328
   Total U.S. dollar-denominated investments in
Aflac Japan                                          $  28,609          $ 

31,031 $ 31,149 $ 35,274

(1) Net of allowance for credit losses


The U.S. Dollar Program includes all U.S. dollar-denominated investments in
Aflac Japan other than the investments in certain consolidated VIEs where the
instrument is economically converted to yen as a result of a derivative in the
consolidated VIE. The Company uses one-sided foreign currency put options to
mitigate the settlement risk on U.S. dollar-denominated assets related to
extreme foreign currency rate changes. From time to time, Aflac Japan also
maintains a collar program on a portion of its U.S. Dollar Program to mitigate
against more extreme moves in foreign exchange and therefore support SMR. As of
September 30, 2022, there were no collars in Aflac Japan, and none of the
Company's foreign currency options hedging Aflac Japan's U.S. dollar-denominated
assets were in-the-money.

In 2021, the Company moved to a strategy that contains one-sided put options,
fewer foreign currency forwards and no collars. The Company believes that the
new strategy will reduce its exposure to pricing volatility and the related risk
of negative settlements should there be a material weakening in the yen.
Depending on further developments, including the possibility of further market
volatility, there may be additional costs associated with maintaining the
options program. The Company is continually evaluating other adjustments,
including the possibility of changing the level of hedging employed with the
U.S. dollar-denominated investments.

As of September 30, 2022, the fair value of Aflac Japan's unhedged U.S.
dollar-denominated portfolio was $10.7 billion (excluding certain U.S.
dollar-denominated assets shown in the table above as a result of consolidation
that have been economically converted to yen using derivatives).


Foreign exchange derivatives used for hedging are periodically settled, which
results in cash receipt or payment at maturity or early termination. The
following table presents the settlements associated with the Company's currency
derivatives used for hedging Aflac Japan's U.S. dollar-denominated investments.

                                        Three Months Ended                   Nine Months Ended
                                          September 30,                        September 30,
(In millions)                         2022                 2021              2022                 2021
Net cash inflows (outflows)              $ (78)           $ (14)               $ (720)           $ 88



                                       98
--------------------------------------------------------------------------------

Enterprise Corporate Hedging Program


The Company has designated certain yen-denominated liabilities and foreign
currency forwards and options of the Parent Company as accounting hedges of its
net investment in Aflac Japan. The Company's consolidated yen-denominated net
asset position was partially hedged at $10.3 billion as of September 30, 2022,
with hedging instruments comprised of $3.6 billion of yen-denominated debt and
$6.7 billion of foreign currency forwards and options, compared with $10.2
billion as of December 31, 2021, with hedging instruments comprised of
$3.3 billion of yen-denominated debt and $6.9 billion of foreign currency
forwards and options.

The Company makes its accounting designation of net investment hedge at the
beginning of each quarter. If the total of the designated Parent Company
non-derivative and derivative notional is equal to or less than the Company's
net investment in Aflac Japan, the hedge is deemed to be effective, and the
currency exchange effect on the yen-denominated liabilities and the change in
estimated fair value of the derivatives are reported in the unrealized foreign
currency component of other comprehensive income. The Company's net investment
hedge was effective during the nine-month periods ended September 30, 2022 and
2021, respectively. For additional information on the Company's net investment
hedging strategy, see Note 4 of the Notes to the Consolidated Financial
Statements.

In order to economically mitigate risks associated with the enterprise-wide
exposure to the yen and the level and volatility of hedge costs, the Parent
Company enters into foreign exchange forward and option contracts. By buying
U.S. dollars and selling yen, the Parent Company is effectively lowering its
overall economic exposure to the yen, while Aflac Japan's U.S. dollar exposure
remains reduced as a result of Aflac Japan's U.S. Dollar Program that
economically creates yen assets. Among other objectives, this strategy is
intended to offset the enterprise-wide amortized hedge costs by generating
amortized hedge income. This activity is reported in Corporate and Other. The
Company continually evaluates the program's efficacy.

Interest Rate Risk Hedge Program


Aflac Japan and Aflac U.S. use interest rate swaps from time to time to mitigate
the risk of investment income volatility for certain variable-rate investments.
Additionally, to manage interest rate risk associated with its U.S.
dollar-denominated investments held by Aflac Japan, from time to time the
Company utilizes interest rate swaptions.

For additional discussion of the risks associated with the foreign currency
exposure refer to the Currency Risk section in Item 7A., Quantitative and
Qualitative Disclosures about Market Risk, and Item 1A, specifically to the Risk
Factors titled "The Company is exposed to foreign currency fluctuations in the
yen/dollar exchange rate" and "Lack of availability of acceptable
yen-denominated investments could adversely affect the Company's results of
operations, financial position or liquidity" in the 2021 Annual Report.

See Note 4 of the Notes to the Consolidated Financial Statements for additional
information on the Company's hedging activities.

                       DEFERRED POLICY ACQUISITION COSTS

The following table presents deferred policy acquisition costs by segment.


                      September 30,
(In millions)             2022                 December 31, 2021                % Change
Aflac Japan                $ 4,931                      $ 6,233                       (20.9) % (1)
Aflac U.S.                   3,224                        3,292                        (2.1)
Total                      $ 8,155                      $ 9,525                       (14.4) %

(1) Aflac Japan's deferred policy acquisition costs decreased .4% in yen during
the nine months ended September 30, 2022.

See Note 6 of the Notes to the Consolidated Financial Statements in the 2021
Annual Report for additional information on the Company's deferred policy
acquisition costs.

                                       99
--------------------------------------------------------------------------------

                               POLICY LIABILITIES

The following table presents policy liabilities by segment.

                                                             September 30,
(In millions)                                                    2022                         December 31, 2021                       % Change
Aflac Japan                                                     $ 74,822                         $  93,613                                    (20.1) % (1)
Aflac U.S.                                                        12,062                            11,916                                      1.2
Other                                                                236                               276                                    (14.5)
Intercompany eliminations(2)                                        (580)                             (733)                                   (20.9)
Total                                                           $ 86,540                         $ 105,072                                    (17.6) %


(1) Aflac Japan's policy liabilities increased .6% in yen during the nine months
ended September 30, 2022.
(2) Elimination entry necessary due to recapture of a portion of policy
liabilities ceded externally, as a result of the reinsurance retrocession
transaction as described in Note 7 of the Notes to the Consolidated Financial
Statements.

                                 BENEFIT PLANS

Aflac Japan and Aflac U.S. have various benefit plans. For additional
information on the Company's Japanese and U.S. plans, see Note 12 of the
accompanying Notes to the Consolidated Financial Statements and Note 14 of the
Notes to the Consolidated Financial Statements in the 2021 Annual Report.

                            POLICYHOLDER PROTECTION

Policyholder Protection Corporation


The Japanese insurance industry has a policyholder protection system that
provides funds for the policyholders of insolvent insurers. Legislation enacted
regarding the framework of the Life Insurance Policyholder Protection
Corporation (LIPPC) included government fiscal measures supporting the LIPPC. In
March 2022, Japan's Diet passed legislation that extended the government's
fiscal support of the LIPPC through March 2027. In March 2022, the LIPPC reached
the required balance for the total life industry of ¥400 billion as specified by
its Articles of Incorporation. As a result, additional contributions are not
expected to be required unless the balance is reduced due to payments made by
the LIPPC to the policyholders of insolvent insurers. Accordingly, Aflac Japan
did not recognize an expense for LIPPC assessments in the third quarter of 2022.
Aflac Japan recognized an expense of ¥.9 billion and ¥1.8 billion for the
nine-month periods ended September 30, 2022 and 2021 for LIPPC assessments.

Guaranty Fund Assessments


Under U.S. state guaranty association laws, certain insurance companies can be
assessed (up to prescribed limits) for certain obligations to the policyholders
and claimants of impaired or insolvent insurance companies that write the same
line or similar lines of business. The amount of the guaranty fund assessment
that an insurer is assessed is based on its proportionate share of premiums in
that state. Guaranty fund assessments for the nine-month periods ended
September 30, 2022 and 2021 were immaterial.

                        LIQUIDITY AND CAPITAL RESOURCES

Liquidity refers to the ability to generate sufficient cash resources to meet
the payment obligations of the Company. Capital refers to the long-term
financial resources available to support the operations of the businesses, fund
business growth and provide for an ability to withstand adverse circumstances.
Financial leverage (leverage) refers to an investment strategy of using debt to
increase the potential ROE. The Company targets and actively manages liquidity,
capital and leverage in the context of a number of considerations, including:

•business investment and growth needs
•strategic growth objectives
•financial flexibility and obligations
•capital support for hedging activity
•a constantly evolving business and economic environment
•a balanced approach to capital allocation and shareholder deployment.

                                      100
--------------------------------------------------------------------------------

The governance framework supporting liquidity, capital and leverage includes
global senior management and board committees that review and approve all
significant capital related decisions.


The Company's cash and cash equivalents include unrestricted cash on hand, money
market instruments, and other debt instruments with a maturity of 90 days or
less when purchased, all of which has minimal market, settlement or other risk
exposure. The target minimum amount for the Parent Company's cash and cash
equivalents is approximately $2.0 billion to provide a capital buffer and
liquidity support at the holding company. This amount excludes $400 million of
proceeds from the issuance of senior sustainability notes in 2021, unallocated
proceeds of which contribute to total cash but are not intended to support
holding company liquidity. The Company remains committed to prudent liquidity
and capital management. At September 30, 2022, the Company held $4.7 billion in
cash and cash equivalents for stress conditions, which includes the Parent
Company's target minimum amount of $2.0 billion.

Aflac Japan and Aflac U.S. generate cash flows from their operations and provide
the primary sources of liquidity to the Parent Company through management fees
and dividends, with Aflac Japan being the largest contributor. The primary uses
of cash by the Parent Company are shareholder dividends, the repurchase of its
common stock, interest on its outstanding indebtedness and operating expenses.

The following table presents the amounts provided to the Parent Company for the
nine-month periods ended September 30.

              Liquidity Provided by Subsidiaries to Parent Company

(In millions)                                  2022         2021

Management fees paid by subsidiaries $ 97 $ 96
Dividends declared or paid by subsidiaries 1,923 2,016

The following table details Aflac Japan remittances, which are included in the
totals above, for the nine-month periods ended September 30.

                            Aflac Japan Remittances

(In millions of dollars and billions of yen)                   2022                     2021

Aflac Japan management fees paid to Parent Company $ 45

$ 44

Aflac Japan dividends declared or paid to Parent Company
(in dollars)

                                                  1,623                    1,776
Aflac Japan dividends declared or paid to Parent Company
(in yen)                                                    ¥ 216.9                  ¥ 195.6



The Company intends to maintain higher than historical levels of liquidity and
capital at the Parent Company for stress conditions and with the goals of
addressing the Company's hedge costs and related potential need for collateral
and mitigating against long-term weakening of the Japanese yen. Further, the
Company plans to continue to maintain a portfolio of unhedged U.S.
dollar-denominated investments at Aflac Japan and to consider whether the amount
of such investments should be increased or decreased relative to the Company's
view of economic equity surplus in Aflac Japan in light of potentially rising
hedge costs and other factors. See the Hedging Activity subsection of this MD&A
for more information.

The Company believes that its balance of cash and cash equivalents and cash
generated by operations will be sufficient to satisfy both its short-term and
long-term cash requirements and plans for cash, including material cash
requirements from known contractual obligations and returning capital to
shareholders through share repurchases and dividends. For additional
information, see the Liquidity and Capital Resources section of Item 7. MD&A in
the 2021 Annual Report.

In addition to cash and cash equivalents, the Company also maintains credit
facilities, both intercompany and with external partners, and a number of other
available tools to support liquidity needs on a global basis. In September 2021,
the Parent Company filed a shelf registration statement with the SEC that allows
the Company to issue an indefinite amount of debt securities, in one or more
series, from time to time until September 2024. The Company believes outside
sources for additional debt and equity capital, if needed, will continue to be
available. Additionally, as of September 30, 2022, the Parent Company and Aflac
had four lines of credit with third parties and ten intercompany lines of
credit. The Company was in compliance with all of the covenants of its notes
payable and lines of credit at September 30, 2022. For additional information,
see Note 8 of the Notes to the Consolidated Financial Statements.

                                      101
--------------------------------------------------------------------------------

The Company's consolidated financial statements convey its financing
arrangements during the periods presented. The Company has not engaged in
material intra-period short-term financings during the periods presented that
are not otherwise reported in its balance sheet or disclosed therein. As of
September 30, 2022, the Company had no material letters of credit, standby
letters of credit, guarantees or standby repurchase obligations. The Company has
not entered into transactions involving the transfer of financial assets with an
obligation to repurchase financial assets that have been accounted for as a sale
under applicable accounting standards, including securities lending
transactions. See Notes 3 and 4 of the Notes to the Consolidated Financial
Statements and Notes 1, 3, and 4 of the Notes to the Consolidated Financial
Statements in the 2021 Annual Report for more information on the Company's
securities lending and derivative activities. See Note 15 of the Notes to the
Consolidated Financial Statements in the 2021 Annual Report for information on
material unconditional purchase obligations that are not recorded on the
Company's balance sheet. With the exception of disclosed activities in those
referenced footnotes and the Risk Factors in the 2021 Annual Report entitled,
"The Company is exposed to foreign currency fluctuations in the yen/dollar
exchange rate" and "Lack of availability of acceptable yen-denominated
investments could adversely affect the Company's results of operations,
financial position or liquidity," the Company is not aware of any trend, demand,
commitment, event or uncertainty that would reasonably result in its liquidity
increasing or decreasing by a material amount.

                            Consolidated Cash Flows

The Company consistently generates positive cash flows from operations, and has
the ability to adjust cash flow management from other sources of liquidity
including reinvestment cash flows and selling investments in order to meet
short-term cash needs.


The Company translates cash flows for Aflac Japan's yen-denominated items into
U.S. dollars using weighted-average exchange rates. In periods when the yen
weakens, translating yen into dollars causes fewer dollars to be reported. When
the yen strengthens, translating yen into dollars causes more dollars to be
reported.

The following table summarizes consolidated cash flows by activity for the
nine-month periods ended September 30.


(In millions)                                     2022         2021
Operating activities                            $ 2,846      $ 4,181
Investing activities                               (847)      (1,171)
Financing activities                             (2,256)      (1,897)

Exchange effect on cash and cash equivalents (84) (46)
Net change in cash and cash equivalents $ (341) $ 1,067

                              Operating Activities

The principal cash inflows for the Company's insurance activities come from
insurance premiums and investment income. The principal cash outflows are the
result of policy claims, operating expenses, income tax, as well as interest
expense. As a result of policyholder aging, claims payments are expected to
gradually increase over the life of a policy. Therefore, future policy benefit
reserves are accumulated in the early years of a policy and are designed to help
fund future claims payments.

The Company expects its future cash flows from premiums and investment
portfolios to be sufficient to meet its cash needs for benefits and expenses.

                              Investing Activities

The Company's investment objectives provide for liquidity primarily through the
purchase of publicly traded investment-grade debt securities. Prudent portfolio
management dictates that the Company attempts to match the duration of its
assets with the duration of its liabilities. Currently, when the Company's fixed
maturity securities mature, the proceeds may be reinvested at a yield below that
required for the accretion of policy benefit liabilities on policies issued in
earlier years. However, the long-term nature of the Company's business and its
strong cash flows provide the Company with the ability to minimize the effect of
mismatched durations and/or yields identified by various asset adequacy
analyses. From time to time or when market opportunities arise, the Company
disposes of selected fixed maturity securities that are available for sale to
improve the duration matching of assets and liabilities, improve future
investment yields, and/or re-balance its portfolio. As a result, dispositions
before maturity can vary significantly from year to year.

                                      102
--------------------------------------------------------------------------------

As part of its overall corporate strategy, the Company has committed $400
million to Aflac Ventures, LLC (Aflac Ventures), as opportunities emerge. Aflac
Ventures is a subsidiary of Aflac Global Ventures, LLC (Aflac Global Ventures)
which is reported in Corporate and other. The central mission of Aflac Global
Ventures is to support the organic growth and business development needs of
Aflac Japan and Aflac U.S. with an emphasis on digital applications designed to
improve the customer experience, gain efficiencies, and develop new markets in
an effort to enhance and defend long-term shareholder value. Investments are
included in equity securities or the other investments line in the consolidated
balance sheets.

As part of an arrangement with Federal Home Loan Bank of Atlanta (FHLB), Aflac
U.S. obtains low-cost funding from FHLB supported by acceptable forms of
collateral pledged by Aflac U.S. In the first nine months of 2022, Aflac U.S.
borrowed and repaid $426 million under this program. As of September 30, 2022,
Aflac U.S. had outstanding borrowings of $592 million reported in its balance
sheet.

See Note 3 of the Notes to the Consolidated Financial Statements for details on
certain investment commitments.

                              Financing Activities

Cash flows from financing activities consist primarily of share repurchases,
dividends to shareholders and from time to time debt issuances and redemptions.


In September 2022, the Parent Company issued four series of senior notes
totaling ¥73.0 billion through a public debt offering under its U.S. shelf
registration statement. The first series, which totaled ¥33.4 billion, bears
interest at a fixed rate of 1.075% per annum, payable semi-annually, and will
mature in September 2029. The second series, which totaled ¥21.1 billion, bears
interest at a fixed rate of 1.320% per annum, payable semi-annually, and will
mature in December 2032. The third series, which totaled ¥6.5 billion, bears
interest at a fixed rate of 1.594% per annum, payable semi-annually, and will
mature in September 2037. The fourth series, which totaled ¥12.0 billion, bears
interest at a fixed rate of 2.144% per annum, payable semi-annually, and will
mature in September 2052. These notes are redeemable at the Parent Company's
option at any time, in whole but not in part, upon the occurrence of certain
changes affecting U.S. taxation, as specified in the indenture governing the
terms of the issuance. In addition, the notes maturing in September 2029,
December 2032 and September 2037 are redeemable at the Parent Company's option,
in whole or in part from time to time, on or after June 14, 2029, June 14, 2032
and March 14, 2037, respectively, at a redemption price equal to the aggregate
principal amount of the applicable series to be redeemed plus accrued and unpaid
interest on the principal amount to be redeemed to, but excluding, the date of
redemption.

In August 2022, the Parent Company renewed a senior term loan facility with a
commitment amount totaling ¥107.0 billion. The first tranche of the facility,
which totaled ¥11.7 billion, bears interest at a rate per annum equal to the
Tokyo interbank market rate (TIBOR), or alternate TIBOR, if applicable, plus the
applicable TIBOR margin and will mature in August 2027. The applicable margin
ranges between .225% and .625%, depending on the Parent Company's debt ratings
as of the date of determination. The second tranche, which totaled
¥25.3 billion, bears interest at a rate per annum equal to TIBOR, or alternate
TIBOR, if applicable, plus the applicable TIBOR margin and will mature in August
2029. The applicable margin ranges between .325% and .725%, depending on the
Parent Company's debt ratings as of the date of determination. The third
tranche, which totaled ¥70.0 billion, bears interest at a rate per annum equal
to TIBOR, or alternate TIBOR, if applicable, plus the applicable TIBOR margin
and will mature in August 2032. The applicable margin ranges between .475% and
1.025%, depending on the Parent Company's debt ratings as of the date of
determination.

In September 2022, the Parent Company used a portion of the net proceeds from
its September 2022 issuance of various series of senior notes and the August
2022 senior term loan facility to redeem $750 million of its 3.625% senior notes
due November 2024.

See Note 8 of the Notes to the Consolidated Financial Statements for further
information on the debt activity discussed above.


Cash returned to shareholders through treasury stock purchases and dividends was
$2.5 billion during the nine-month period ended September 30, 2022, compared
with $2.3 billion during the nine-month period ended September 30, 2021.

The following tables present a summary of treasury stock activity during the
nine-month periods ended September 30.

                                      103
--------------------------------------------------------------------------------

                            Treasury Stock Purchased

(In millions of dollars and thousands of shares)     2022         2021
Treasury stock purchases                           $ 1,801      $ 1,676
Number of shares purchased:
Share repurchase program                            30,249       32,186
Other                                                  354          419
  Total shares purchased                            30,603       32,605



                             Treasury Stock Issued

(In millions of dollars and thousands of shares) 2022 2021
Stock issued from treasury:

  Cash financing                                   $    15      $    13
  Noncash financing                                     45           43
  Total stock issued from treasury                 $    60      $    56
Number of shares issued                              1,109        1,424



As of September 30, 2022, a remaining balance of 25.6 million shares of the
Company's common stock was available for purchase under share repurchase
authorizations by its board of directors.

In August 2022, the IRA was signed into U.S. law. Effective January 1, 2023, the
law will impose a 1% excise tax on the Company's repurchases of its common
stock.


Cash dividends paid to shareholders were $.40 per share in the third quarter of
2022, compared with $.33 per share in the third quarter of 2021. The following
table presents the dividend activity for the nine-month periods ended
September 30.

(In millions)                                    2022       2021
Dividends paid in cash                          $ 740      $ 647

Dividends through issuance of treasury shares 28 23
Total dividends to shareholders

                 $ 768      $ 670



In October 2022, the board of directors declared the fourth quarter cash
dividend of $.40 per share, an increase of 21.2% compared with the same period
in 2021. The dividend is payable on December 1, 2022 to shareholders of record
at the close of business on November 16, 2022.

                            Regulatory Restrictions

Aflac Japan


Aflac Japan is required to meet certain financial criteria as governed by
Japanese corporate law in order to provide dividends to the Parent Company.
Under these criteria, dividend capacity at the Japan subsidiary is basically
defined as total equity excluding common stock, accumulated other comprehensive
income amounts, capital reserves (representing statutorily required amounts in
Japan) but reduced for net after-tax unrealized losses on available-for-sale
securities. These dividend capacity requirements are generally aligned with the
SMR. Japan's FSA maintains its own solvency standard which is quantified through
the SMR. Aflac Japan's SMR is sensitive to interest rate, credit spread, and
foreign exchange rate changes, therefore the Company continues to evaluate
alternatives for reducing this sensitivity, including the reduction of
subsidiary dividends paid to the Parent Company and Parent Company capital
contributions. In the event of a rapid change in market risk conditions causing
SMR to decline, the Company has one senior unsecured revolving credit facility
in the amount of ¥100 billion and a committed reinsurance facility in the amount
of approximately ¥120 billion as a capital contingency plan. Additionally, the
Company could take action to enter into derivatives on unhedged U.S.
dollar-denominated investments with foreign currency options or forwards. See
Notes 7 and 8 of the Notes to the Consolidated Financial Statements for
additional information.

The Company has already undertaken various measures to mitigate the sensitivity
of Aflac Japan's SMR. For example, the Company employs policy reserve matching
(PRM) investment strategies, which is a Japan-specific accounting
                                      104
--------------------------------------------------------------------------------

treatment that reduces SMR interest rate sensitivity since PRM-designated
investments are carried at amortized cost consistent with corresponding
liabilities. In order for a PRM-designated asset to be held at amortized cost,
there are certain criteria that must be maintained. The primary criterion
relates to maintaining the duration of designated assets and liabilities within
a specified tolerance range. If the duration difference is not maintained within
the specified range without rebalancing, then a certain portion of the assets
must be re-classified as available for sale and held at fair value with any
associated unrealized gain or loss recorded in surplus. To rebalance, assets may
need to be sold in order to maintain the duration with the specified range,
resulting in realizing a gain or loss from the sale. For U.S. GAAP, PRM
investments are categorized as available for sale. The Company also uses foreign
currency derivatives to hedge a portion of its U.S. dollar-denominated
investments. See Notes 3, 4 and 8 of the Notes to the Consolidated Financial
Statements in the 2021 Annual Report for additional information on the Company's
investment strategies, hedging activities, and reinsurance, respectively.

As of September 30, 2022, Aflac Japan's SMR remains high and reflects a strong
capital and surplus position. The Company is committed to maintaining strong
capital levels, consistent with maintaining current insurance financial strength
and credit ratings.

Aflac U.S.

A life insurance company's statutory capital and surplus is determined according
to rules prescribed by the National Association of Insurance Commissioners
(NAIC), as modified by the insurance department in the insurance company's state
of domicile. Statutory accounting rules are different from U.S. GAAP and are
intended to emphasize policyholder protection and company solvency. The
continued long-term growth of the Company's business may require increases in
the statutory capital and surplus of its insurance operations. The Company's
insurance operations may secure additional statutory capital through various
sources, such as internally generated statutory earnings, reduced dividends paid
to the Parent Company, capital contributions by the Parent Company from funds
generated through debt or equity offerings, or reinsurance transactions. The
NAIC's Risk-based capital (RBC) formula is used by insurance regulators to help
identify inadequately capitalized insurance companies. The RBC formula
quantifies insurance risk, business risk, asset risk and interest rate risk by
weighing the types and mixtures of risks inherent in the insurer's operations.
As of September 30, 2022, Aflac's RBC ratio remains high and reflects a strong
capital and surplus position.

Aflac, CAIC and TOIC are domiciled in Nebraska and are subject to its
regulations. The maximum amount of dividends that can be paid to the Parent
Company by Aflac, CAIC and TOIC without prior approval of Nebraska's director of
insurance is the greater of the net income from operations, which excludes net
investment gains, for the previous year determined under statutory accounting
principles, or 10% of statutory capital and surplus as of the previous year-end.
Dividends declared by Aflac during 2022 in excess of $1.1 billion would be
considered extraordinary and require such approval. Similar laws apply in New
York, the domiciliary jurisdiction of Aflac New York.

                      Privacy and Cybersecurity Governance

The Company's Board of Directors has adopted an information security policy
directing management to establish and operate a global information security
program with the goals of monitoring existing and emerging threats and ensuring
that the Company's information assets and data, and the data of its customers,
are appropriately protected from loss or theft. The Board has delegated
oversight of the Company's information security program to the Audit and Risk
Committee. The Company's senior officers, including its Global Security and
Chief Information Security Officer, are responsible for the operation of the
global information security program and communicates quarterly with the Audit
and Risk Committee on the program, including with respect to the state of the
program, compliance with applicable regulations, current and evolving threats,
and recommendations for changes in the information security program. The global
information security program also includes a cybersecurity incident response
plan that is designed to provide a management framework across Company functions
for a coordinated assessment and response to potential security incidents. This
framework establishes a protocol to report certain incidents to the Global
Security and Chief Information Security Officer and other senior officers, with
the goal of timely assessing such incidents, determining applicable disclosure
requirements and communicating with the Audit and Risk Committee. The incident
response plan directs the executive officers to report certain incidents
immediately and directly to the Lead Non-Management Director.

                                     Other

For information regarding commitments and contingent liabilities, see Note 13 of
the Notes to the Consolidated Financial Statements.

                                      105
--------------------------------------------------------------------------------

                             Additional Information

Investors should note that the Company announces material financial information
in its SEC filings, press releases and public conference calls. In accordance
with SEC guidance, the Company may also use the Investor Relations section of
the Company's website (http://investors.aflac.com) to communicate with investors
about the Company. It is possible that the financial and other information the
Company posts there could be deemed to be material information. The information
on the Company's website is not part of this document. Further, the Company's
references to website URLs are intended to be inactive textual references only.

                         CRITICAL ACCOUNTING ESTIMATES

The Company prepares its financial statements in accordance with U.S. GAAP.
These principles are established primarily by the Financial Accounting Standards
Board (FASB). In this MD&A, references to U.S. GAAP issued by the FASB are
derived from the FASB Accounting Standards Codification™ (ASC). The preparation
of financial statements in conformity with U.S. GAAP requires the Company to
make estimates based on currently available information when recording
transactions resulting from business operations. The estimates that the Company
deems to be most critical to an understanding of its results of operations and
financial condition are those related to the valuation of investments and
derivatives, DAC, liabilities for future policy benefits and unpaid policy
claims, and income taxes. The preparation and evaluation of these critical
accounting estimates involve the use of various assumptions developed from
management's analyses and judgments. The application of these critical
accounting estimates determines the values at which 92% of the Company's assets
and 78% of its liabilities are reported as of September 30, 2022, and thus has a
direct effect on net earnings and shareholders' equity. Subsequent experience or
use of other assumptions could produce significantly different results.

There have been no changes in the items the Company has identified as critical
accounting estimates during the nine months ended September 30, 2022. For
additional information, see the Critical Accounting Estimates section of Item 7.
MD&A included in the 2021 Annual Report.

Future Adoption of Accounting Standard for Long-Duration Insurance Contracts


As previously reported, in August 2018, the FASB issued Accounting Standards
Update 2018-12, "Financial Services - Insurance, Targeted Improvements to the
Accounting for Long-Duration Contracts" (the ASU). The update significantly
changes how insurers account for long-duration contracts, amends existing
recognition, measurement, presentation, and disclosure requirements applicable
to the Company.

The following table presents the expected impacts from the adoption of ASU
2018-12 to the Company's previously reported operating ratios.


                          Year ended December 31, 2021

                                                  As                            As
                                              Previously                     Adjusted
                                               Reported
Aflac Japan: (1)
Ratios to total premiums:
Benefits and claims, net                             67.0  %                      67.9  %
Ratios to total adjusted revenues:
Total adjusted expenses                              21.6                         20.5
Aflac U.S.:
Ratios to total premiums:
Benefits and claims, net                             43.6  %                      47.0  %
Ratios to total adjusted revenues:
Total adjusted expenses                              39.5                   

38.4

(1) Includes the impact of the deferred profit liability reclassification
discussed in Note 1 of the Notes to the Consolidated Financial Statements.


For the year ended December 31, 2021, as restated under the new ASU, benefit
ratios are higher for Aflac Japan and Aflac U.S., while expense ratios are
modestly lower due to amortizing deferred acquisition costs at a slower rate.
This
                                      106
--------------------------------------------------------------------------------

results in a slightly higher pretax profit margin for Aflac Japan and a modestly
lower pretax profit margin for Aflac U.S. The pre-adoption and restated ratios
presented above reflect the deferred profit liability reclassification discussed
in Note 1 of the Notes to the Consolidated Financial Statements.

Prior to adoption of the ASU, pandemic-related low claim experience is
recognized in earnings in the reporting period when low claims are experienced,
whereas under the new ASU, this pandemic-related low claim experience is
recognized in line with experience-related remeasurement and potentially through
annual assumptions updates, i.e., partially during the reporting period with the
remainder recognized over the remaining expected life of each cohort.

For additional information on the ASU, see the Future Adoption of Accounting
Standard for Long-Duration Insurance Contracts section of Item 7. MD&A in the
2021 Annual Report; see also Note 1 of the Notes to the Consolidated Financial
Statements.

New Accounting Pronouncements

For information on new accounting pronouncements and the impact, if any, on the
Company's financial position or results of operations, see Note 1 of the Notes
to the Consolidated Financial Statements.

Older

NMI HOLDINGS, INC. – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations

Newer

health care Some health insurancesseem too good to be true

Advisor News

  • When new investment trends emerge, Gen Z is most likely generation to be first in
  • Could ‘plain English’ become an advisor’s secret weapon?
  • IRI urges Senate action on 403(b) parity legislation
  • Three estate planning ideas to protect your clients and their wealth
  • What advisors must know about accessible client documents
More Advisor News

Annuity News

  • NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
  • NAIC working group pressed to accelerate annuity illustration overhaul
  • State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
  • Wink: Annuity sales post strong Q2, led by MYGAs and structured products
  • Legacy Marketing Group partners with Malibu Life USA for annuity launch
More Annuity News

Health/Employee Benefits News

  • $4B at stake in Medicaid change
  • ATTORNEY GENERAL TONG JOINS COALITION CHALLENGING TRUMP ADMINISTRATION'S LATEST ATTACK ON HEALTHCARE FOR TRANSGENDER YOUTH
  • ATTORNEY GENERAL TONG JOINS LAWSUIT CHALLENGING EFFORT TO EXPAND CATASTROPHIC HEALTH INSURANCE PLANS AND AGAIN UNDERMINE ACA PROTECTIONS
  • ATTORNEY GENERAL TONG URGES CONNECTICUT INSURANCE DEPARTMENT TO REJECT DOUBLE-DIGIT HEALTH INSURANCE RATE HIKE REQUESTS
  • Some WNY health insurance rates will stay flat. Others will rise 13.5%
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • TDCI reminds consumers to focus on future during Life Insurance Awareness Month
  • TDCI reminds consumers to focus on the future during Life Insurance Awareness Month
  • AM Best Affirms Credit Ratings of Zurich Insurance Group Ltd and Its Main Rated Subsidiaries
  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on China’s Non-Life Insurance Segment
  • Understanding Nonequity Split-Dollar
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
  • MassMutual Ascend Surpasses $2 Billion in Lifetime Advisory Annuity Sales, Reflecting Continued Momentum in RIA Channel
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.